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Abstract
The Baeyer-Villiger reaction is a very important oxidative reaction in organic
synthesis that leads to the production of optically pure esters and lactones from
ketones. It is typically performed by peroxyacids, oxydative reagents that are
toxic, hazardous and lacking selectivity. By using “green chemistry”, it is possible
to perform the same reaction using “bio-catalyzers”, enzymes named Baeyer-
Villiger monoxygenases (BVMOs), a group of flavin dependent monooxygenases,
that use NAD(P)H and molecular oxygen in order to catalyze chemo-, regio-,
and enantio-selective oxidative reactions. BVMOs have been identified in a large
number of bacteria and fungi but only a restricted number of them is available in
recombinant form. In order to discover novel BVMOs, new sources of enzymes
will become important.
Using bioinformatics tools, we have identified and selected five new putative
type I BVMOs from different organisms: Oryza sativa (Os; plant), Physcomitrella
patens (Pp; moss), Cyanidioschyzon merolae (Cm; red alga), Trichodesmium
erythraeum (Te; cyanobacterium), Haloterrigena turkmenica (Ht; archeabac-
terium). In particular, basing on most updated literature, the photosynthetic
eukaryotes Oryza, Physcomitrella and Cyanidioschyzon would result very un-
common sources for BVMOs.
The cloning and expression strategy used was the same for all the five pu-
tative sequences. The very low solubility of the expressed proteins was the real
bottleneck of the work. To overcome the solubility problem many strategies have
been performed lowering the inducer concentration, the growth temperature and
using chaperones. Adding on the culture an excess of riboflavin, the precursor of
the FAD, results successful to obtain soluble flavoproteins from Physcomitrella
patens and Cyanidioschyzon merolae, showing the importance of the flavin co-
factor in the folding process.
A biocatalytic characterisation of both expressed proteins was made at the
Molecular Enzymology group of the Groningen Biomolecular Science and Biotech-
nology Institute (GBB), University of Groningen (The Netheralnds) headed by
Prof. Dr. M.W. Fraaije, a main expert in flavoenzymes and particularly in
Baeyer-Villiger monooxygenses. Once verified their Baeyer-Villiger monooxyge-
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nase activity a condition optimization (pH, temperature and stability) has been
performed; then the two proteins were tested to investigate their substrate speci-
ficity. A steady-state study was carried out in order to obtain kinetics parameters
and many conversions were made to determine their selectivity profile.
The work presented led to discover new type I BVMOs enlarging the possi-
bility to find out novel and promising biocatalysts for oxidative reactions.
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Riassunto
La reazione di Baeyer-Villiger e` una reazione di ossidazione di grande in-
teresse sintetico in chimica organica e consiste nella conversione di composti
carbonilici nei corrispondenti esteri o lattoni. L’approccio classico per eseguire
la reazione di Baeyer-Villiger prevede l’utilizzo di agenti ossidanti quali perossidi
o perossiacidi; questi catalizzatori sono tuttavia il piu` delle volte intrinsecamente
insatabili e/o tossici mancando anche di enantioselettivita`. Cio` ha portato allo
sviluppo di differenti sistemi catalitici che hanno implementano il concetto di
“green chemistry” quali gli enzimi, utilizzati come biocatalizzatori. Gli enzimi
che in natura catalizzano la reazione di Baeyer-Villiger sono flavoenzimi chiamati
“Bayer-Villiger monoossigenasi” (BVMOs). Ad oggi solo pochi geni codificanti
per le BVMOs sono stati clonati ed espressi e cio` ha rappresentato sicuramente
un grosso ostacolo verso l’applicazione industriale di questa classe di enzimi.
Attraverso un’analisi bioinformatica e` stato possibile identificare cinque se-
quenze codificanti proteine ritenute BVMOs putative, le quali presentano al loro
interno il motivo caratteristico delle BVMOs di tipo I (FxGxxxHxxxW). Gli or-
ganismi individuati sono stati i seguenti: Oryza sativa (pianta), Physcomitrella
patens (muschio), Cyanidioschyzon merolae (alga rossa), Trichodesmium ery-
thraeum (cianobattere), Haloterrigena turkmenica (archeobattere). In partico-
lare gli eucarioti fotosintetici Oryza, Physcomitrella e Cyanidioschyzon risultano
fonti di BVMOs alquanto inusuali, considerando che fino ad oggi questi enzimi
sono stati identificati solamente in batteri e funghi.
La strategia di clonaggio e di espressione utilizzate e` stata la stessa per tutte
e cinque le sequenze identificate. La bassa solubilita` delle proteine espresse si e`
rivelata il fattore limitante di tutto il lavoro. Le strategie utilizzate per miglio-
rare la solubilita` proteica sono state quelle che hanno portano a una diminuzione
della velocita` della sintesi proteica come ad esempio la diminuzione della temper-
atura di crescita di coltura e la diminuzione della concentrazione dell’induttore.
Un fattore risolutivo e` stato l’aggiunta al terreno di coltura di riboflavina, il
precursore del FAD, il quale ha permesso di ottenere in forma solubile le pro-
teine putative da Physcomitrella patens e Cyanidioschyzon merolae, dimostrando
inoltre l’importanza del cofattore flavinico nel processo di ripiegamento proteico.
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La caratterizzazione biocatalitica delle proteine espresse e` stata eseguita presso
il gruppo di Biocatalisi del Groningen Biomolecular Sciences and Biotechnol-
ogy Institute (GBB), University of Groningen (The Netheralnds), guidato dal
Prof. Dr. M.W. Fraaije, esperto in flavoproteine. Confermata la loro attivita`
come Baeyer-Villiger monoossigenasi e` stata eseguita un’ottimizzazione delle con-
dizioni di reazione (in termini di pH, temperatura e stabilita`) ed e` stata investi-
gata la loro specificita` di substrato. In seguito sono stati determinati i parametri
cinetici per ciascun enzima e infine sono state eseguite delle bioconversioni con
diversi substrati per capire il loro profilo di selettivita`.
Il lavoro riportato ha portato alla scoperta di nuove Baeyer-Villiger monoos-
sigenasi di tipo I, ampliando il panorama di nuovi promettenti biocatalizzatori
ossidoriduttivi.
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Chapter 1. General introduction
1.1 Biocatalysis as a green synthetic tool
1.1.1 Green Chemistry
Traditionally Chemistry is defined as the study of the nature, properties, and
composition of matter, and how these undergo changes. In organic chemistry
carbon-based compounds are the matter of this study and, chemical reactions
between organic compounds are used in nature and in organic synthesis to build-
up new organic molecules. In general, these structurally different organic com-
pounds represent not only the base of living organisms but they are important
components of many products used in human life, such as drugs, plastics, petro-
chemicals and their derivatives. Development and optimization of chemical pro-
cesses, employed for transforming basic organic compounds into useful products
for human society, are what industrial chemistry is based on.
Approximately during the two last centuries, chemical industry dramatically
transformed the world’s economy; in fact chemical processes have created agro-
chemicals such as pesticides and fertilizers, drugs and pharmaceuticals products,
synthetic dyes and chemical fibers, flavors for the food industry, plastics, syn-
thetic resins, photo chemicals and many other chemical products which have
played an important role in transforming modern society from a economical, en-
vironmental, even social and political point of view. Such a variety of goods
has been extremely responsible for the high standard of life in modern indus-
trialized society. On the other hand, all these benefits for human living led to
a big exploitation of non-renewable natural sources and a massive use of toxic
and hazardous feedstock and catalysts, generating dangerous by-products for the
environment.
In the 1960s it had become evident that air, water and land pollution was
overcoming the limits, so many countries started a notable legislative action to
reduce pollutants from wasted sites. Many advanced technologies to control pol-
lution were implemented in the so-called “command and control” approach, im-
proving successfully the environmental quality. However, a better system would
consist in preventing pollutions at its source rather than acting afterwards to
minimize it.
In 1990 the Pollution Prevention Act was passed in the United States putting
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the bases for the Green Chemistry approach, an innovative and philosophical way
toward sustainability. In the same years, Anastas of the US Environmental Pro-
tection Agency (EPA) coined the term “Green Chemistry” [4] and in 1993 the
EPA officially adopted the name “US Green Chemistry Program”. Green chem-
istry can be applied to any chemical sector, redesigning products and processes
that minimize the use of hazardous substances and maximizing the efficiency
of any chemical choice [3, 6, 5, 4]. The essence of this new approach has been
defined as follows [98]:
Green chemistry efficiently utilizes (preferably renewable) raw materials, elim-
inates waste and avoids the use of toxic and/or hazardous reagents and solvents
in the manufacture and application of chemical products.
This concept is embodied into 12 basic Principles:
1. Waste prevention instead of remediation
2. Atom efficiency
3. Less hazardous/toxic chemicals
4. Safer products by design
5. Innocuous solvents and auxiliaries
6. Energy efficient by design
7. Preferably renewable raw materials
8. Shorter syntheses (avoid derivatization)
9. Catalytic rather than stoichiometric reagents
10. Design products for degradation
11. Analytical methodologies for pollution prevention
12. Inherently safer processes
Maximizing the percent yield was the traditional goal to evaluate a chemical
process, while the new developed concept is focused in minimizing waste to the
molecular level; this means that, in a designed process, the amount of starting
material should end up in the generated product without atom waste. Atom
economy can be improved carefully choosing suitable starting materials and cat-
14
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alyst systems. In fact in many cases waste, generated in chemical processes, is a
consequence of required stoichiometric amounts of reagents and catalysts. The
use of catalytic quantities represents a solution to “clean” classical stoichiometric
methodologies and if the catalyst is really “green” it can be recovered and reused
many times in the same process [97, 27, 28].
1.1.2 Biocatalysis
Biocatalysis, that is the use of natural catalysts such as enzymes to perform
chemical transformations on organic compounds, represents a good opportunity
from the green chemistry point of view, because enzymes usually operate in mild
reaction conditions (room temperature and physiological pH), are biodegradable
catalysts derived from a renewable sources and use water as solvent [116]. More-
over, their chiral nature results in high chemo-, regio- and stereoselectivity with
excellent rate acceleration, a very important feature for chemical organic syn-
thesis. However, the fulfillment of an enzymatic reaction is not so obvious and
can be affected by several parameters (Fig. 1.1), such as specific activity (quan-
tified by k cat), specificity (determined by k cat/KM), stability and the degree of
inhibition by substrate or product. The ideal biocatalyst would have high spe-
cific activity, high selectivity and stability with a minimal substrate and product
inhibition (Fig. 1.1) [57].
Figure 1.1: Parameters to be considered for enzymatic synthesis. (Image from Nature
409, 232-240 (11 January 2001), doi:10.1038/35051706).
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Over the last two decades, advances in DNA recombinant technologies have
enabled manipulation of enzymes and their consequent application in industrial
organic synthesis. In fact, protein-engineering techniques have permitted alter-
ation of their substrate specificity and stability ,and increase of their specific
activity by developing enzyme variants with modified properties, adapted for
new process conditions [13]. However the success of biocatalysis depends on the
feasibility of the specific process from an economical point of view. Comparing
conventional chemical methods with biocatalytic processes, the development of
the latter ones is usually much longer to be established and requires inputs from
different science fields such as chemical engineering, chemistry, biochemistry and
molecular biology.
Figure 1.2: The biocatalysis cycle. (Image from Nature 409, 258-268(11 January
2001), doi:10.1038/350517369).
To develop a biocatalytic process (Fig 1.2) the starting point should usually be
the product, which can be produced by one or more biocatalytic reactions. One
or more biocatalysts can be identified or developed, but the key point is that
resulting bioconversions need to be economically feasible. Thus, an economic
analysis-based approach is necessary to identify process bottlenecks and try to
16
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overcome these limitations in an iterative way, gradually leading to an efficient
industrial process [96]. On the basis of the impact of biocatalysis on the synthesis
of chiral drug candidates, several pharmaceutical companies have dedicated great
emphasis on biocatalysis for organic synthesis. Some examples are BASF, DSM,
Lonza, Merck, Pfizer, Bristol Myers Squibb and Codexis.
1.2 Monooxygenases
Monooxygenases (EC 1.13.x.x and EC 1.14.x.x) are oxygenase enzymes able to
catalyze the transfer of one atom of oxygen to an organic substrate, and reduce
the other atom of oxygen to water. Monooxygenases represent very interesting
enzymes for synthetic purpose because the insertion of one atom of oxygen into an
organic molecule is difficult to obtain in a chemical way. In fact molecular oxygen
by itself cannot perform a direct oxidation reaction because of its spin-state,
but it needs activation. Oxidizing enzymes such as monooxygeanases (but also
dioxygenases) are able to carry out activation providing electrons to molecular
oxygen, after which oxygenation of the organic substrate can occur [17]. There
are many reactions catalyzed by these enzymes interesting from a synthetic point
of view such as heteroatom oxidation, aromatic and aliphatic hydroxylation,
epoxidation and Baeyer-Villiger oxidation (Fig 1.3).
Figure 1.3: Examples of reactions catalysed by monnoxygenase. (Image from Enzyme
Catalysis in Organic Synthesis. A Comprehensive Handbook, Vol. III).
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Generally they utilize NADH or NADPH to provide reducing potential (exter-
nal monooxygenases) together with a wide range of prosthetic groups/cofactors,
including iron (e.g., cytochrome P450), copper (e.g., dopamine β monooxyge-
nase), pterins, and flavins. In some cases no cofactor is even present; such
internal monooxygenases provide electrons from the substrate itself.
Internal monooxygenase reaction: XH2 + O2 → XO + H2O
External monooxygenase reaction: X + O2 + DH + H
+ → XO + H2O + D+
1.3 Baeyer-Villiger Monooxygenases
1.3.1 Baeyer-Villiger reaction
The Baeyer-Villiger reaction was first reported by Adolf von Baeyer and Victor
Villiger in 1899 [8]. In this organic reaction ketones are oxidized into correspond-
ing esters or lactones by peroxyacids resulting in oxygen insertion next to the
carbonyl group. The reaction mechanism consists in the nucleophilic attack of
peroxy acid to the carbonyl function forming a tetrahedral intermediate called
the “Criegee intermediate” which undergoes rearrangement to the corresponding
ester or lactone; one of the group attached to carbonyl carbon migrates to the
electron deficient oxygen atom with the simultaneous dissociation of the O-O
bond; proper alignment of orbitals is required for the rearrangement step, which
is the rate-limiting step of the reaction [32].
Figure 1.4: Mechanism of the Baeyer-Villiger reaction.
The regiochemistry of the reaction depends on the relative migratory ability
18
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of the substituents attached to the carbonyl group (Fig. 1.4). Substituents which
are able to stabilize a positive charge migrate more readily, so that the migratory
aptitude is: tertiary alkyl > cyclohexyl > secondary alkyl > phenyl > primary
alkyl > CH3 [90]. Stereoeletronic factors can also affect the regiochemical result;
indeed, in the transition state the antiperiplanar alignment of the migrating sub-
stituent (Rm) and the O-O bond of the leaving group (primary stereoeletronic
effect) and another antiperiplanar alignment of alone pair of oxygen with the
migrating group (secondary stereoeletronic effect), are required. Moreover, if
the migrating carbon is chiral the stereochemistry is retained [30]. As above
mentioned, reagents able to carry out the Baeyer-Villiger reaction are peroxy
acids such as meta-chloroperoxybenzoic acid (m-CPBA), trifluoroperoxyacetic
acid (TFPPA), peroxyacetic acid, monopermalic acid, p-nitrobenzoic acid and
hydrogen peroxide. Organic peroxy acids are expensive, toxic and hazardous;
they are strong oxidants and react with other functional groups. Moreover being
achiral they lack selectivity, a very important feature in organic synthesis, be-
cause of the need to produce enantiopure compounds. Many therapeutic drugs,
but also fragrances and agrochemicals can achieve their biological effect only
in a specific enantiomeric form and enzymatic reactions are very good tools to
perform asymmetric catalysis.
1.3.2 Enzyme-catalysed Baeyer-Villiger reaction
Baeyer-Villiger monooxygenases are flavin-dependent monooxygenases able to
catalyse nucleophilic oxidation of carbonyl groups but also the electrophilic ox-
idation of heteroatoms such as sulphur, nitrogen and boron, with good enan-
tioselctivity. In fact, from an industrial point of view, the great potential of
these enzymes is the possibility to produce chiral lactones and sulfoxides by
asymmetric synthesis, attractive for organic synthesis. BVMOs contain flavin
cofactor, FAD or FMN, not covalently but tightly bound to the enzyme. This
flavin-cofactor has to be activated by electron donors, NADH or NADPH, which
give reduction equivalents allowing molecular oxygen binding. Depending on
cofactors usage, BVMOs can be classified into two types [114].
Type I BVMOs are FAD and NADPH dependent and contain two-dinucleotide
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binding-domain (βαβ-folds) known as Rossman motifs, one for the FAD binding
and the other one for the NADPH binding. They are composed of only one
polypeptide. Type II BVMOs are FMN and NADH dependent and consist into
two distinct subunits, a dehydrogenase subunit using NADH to reduce FMN
and a second subunit able to perform the Baeyer-Villiger reaction using reduced
flavin. There is another monooxygenase, MtmOIV, involved in the biosynthesis
of mithramycin, able to perform the Baeyer-Villiger reaction. Mithramycin is
a polyketide anticancer antibiotic produced by the soil bacterium Streptomyces
argillaceus (ATCC 12956) and other bacteria of the genus Streptomyces [9]. Se-
quence analysis and crystal structure revealed that MtmVIO cannot be classified
as type I nor type II BVMO but it appears to be an atypical BVMO belonging to
another flavoprotein family (for flavoprotein monooxygenases classification, see
[12]. The main described and characterized enzymes are type I BVMOs, which
display good substrate promiscuity and are thus attractive from a synthetic point
of view [74].
1.3.3 Mechanism of action of type I BVMOs
The first general accepted mechanism, proposed by Walsh et al. [92], was de-
signed for cyclohexanone monooxygenases (CHMO) from A. calcoaceticus NCIMB
9871. Mechanistic studies were then performed by Massey et al. on the same
enzyme [99], elucidating the presence of intermediates involved in catalysis. Fur-
ther investigation by Torres Pazmin˜o et al. on the kinetic mechanism of PAMO
has elucidated the ability of these enzymes to catalyze not only the nucleophilic
attack on the carbonyl group but also the eletrophilic reaction according to the
peroxy-intermediate formed [79].
The biocatalytic cycle (Fig. 1.5) starts with FAD reduction mediated by
NADPH to form an enamine intermediate, which readily reacts with molecular
oxygen leading to the nucleophilic 4a-peroxyanion in equilibrium with the corre-
sponding electrophilic 4a-hdroperoxyflavin [99]. Thus, depending on the proto-
nation state of the formed oxygenated flavin-intermediate, flavoprotein monooxy-
genases are able to perform Baeyer-Villiger oxidation or heteroatom oxidation,
showing the double oxidative functionality (nucleophilic and electrophilic) of the
20
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Figure 1.5: Mechanism of action of flavin-dependent type I BVMOs.
reactive intermediate species. In the nucleophilic oxidation, 4a-peroxyflavin at-
tacks the keto group (C=O) of the substrate to produce a tetrahedral Criegee
intermediate, which rearranges forming an ester or lactone and a hydroxyflavin
(FAD-OH); it then eliminates water to close the catalytic cycle. It is known
that the oxidized NADP+ remains in the active site till the oxygenation occurs,
stabilizing the negatively charged peroxyflavin-intermediate. In the protonated
form, hydroperoxyflavin is able to oxidize the substrate by electrophilic addition
and, as the product is released from the enzyme complex, FAD-OH is formed as
for the nucleophilic process [79].
1.3.4 Structural features
The first crystal structure of a BVMO was solved by Malito et al. in 2004 [69],
who published the three dimensional structure of PAMO (pdb-code 1W4X). The
enzyme has two domains with the active site located in a cleft at the domain
interface. The FAD-binding domain is linked to the NADPH-binding domain
by a linker region containing the “fingerprint” motif FxGxxHxxxWP/D, a con-
served sequence shared by all type I BVMOs. Moreover each domain contains a
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dinucleotide-binding motif (part of Rossman fold), one for the FAD and the other
for NADPH/NADP+. The latter one interacts with two important residues,
R217 and K336, having a role in affinity and recognition of the ribose moiety of
NADPH. Located on the re side of the flavin ring there is R337, another con-
served residue among BVMOs. It adopts two alternative conformations during
the biocatalytic cycle: a IN position, which stabilizes the negatively charged
flavin-peroxide intermediate, and an OUT position, responsible for the position-
ing to perform FAD reduction. Finally H173, which is part of the “fingerprint”
motif, has a critical role in FAD binding, domain rotation and conformational
changes during the biocatalysis [69]. Since 2011 different 3D-structures of PAMO
were solved elucidating the structural mechanism of the oxidation process [83].
Figure 1.6: Crystal structure of PAMO dimer. (Image from PNAS,101(36),2004)
[69].
In addition to PAMO, other BVMO structures were solved in recent years. In
2009 MtmOIV from Streptomyces argillaceus (ATCC 12956) was crystallized by
Beam et al. (pdb-code 3fmw) [9]. The enzyme, involved in mithramycin biosyn-
thetic pathway, is a dimer lacking the characteristic conserved “fingerprint” motif
of type I BVMOs. It is considered an example of atypical class A flavoprotein
monooxygenase catalyzing a Baeyer-Villiger oxidation, since it requires perox-
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yflavin intermediate for the nucleophilic attack to the carbonyl function instead
of the hydroxyl-flavin to perform an electrophilic oxidation. Its active site con-
tains R52, the equivalent of R337 in PAMO, but located at the si side of the
flavin ring.
Another crystal structure is the one of CHMO from a soil actinomycete
Rhodococcus sp. HI-31 solved in two different crystal forms, closed and opened
(pdb-code CHMOclosed 3gwd, pdb-code CHMOopen 3wdf). The enzyme has a
three-domain architecture, a FAD binding domain a NADPH binding domain
and, in between the two ones, a modulating domain which contains residues of
the substrate binding poket. Moreover, numerous loops give to the enzyme a
high conformational flexibility, in particular concerning the two different con-
formations of the nicotinamide cofactor domain. This suggests a large shift re-
sponsible for changing the size and accessibility of the substrate-binding pocket
allowing the accommodation of a broad range of substrates [77].
In 2012 OTEMO, a type I BVMO catalyzing the lactonization of 2-oxo-3-
4,5,5-trimethylcyclopentenylacetylcoenzymeA (CoA), a key intermediate in the
metabolism of camphor by Pseudomonas putida ATCC 17453, has been solved
[64]. The enzyme is a dimer in solution; each monomer consists of three domains
(a FAD-binding domain, a NADPH binding domain and a “flap” domain) with
bound flavin (pdb code 3UOV) as well as FAD and NADP (pdb code 3UOY).
A comparison of various crystals of OTEMO bound to FAD and NADP+ re-
vealed the conformational plasticity of several loop regions, some of which have
been implicated in contributing to the substrate specificity profile of structurally
related BVMOs [33].
In the same year the crystallographic structure of steroid monooxygenase
(STMO) from Rhodococcus rhodochrous (pdb code 4AOX), which exhibits the
typical two-domain organization, was also solved . The active site resembles
that of PAMO and the binding-site for NADP+ with respect to the flavin is
shifted compared with what observed in other type I BVMOs. This finding fully
supports the idea that NADP(H) adopts various positions during the catalytic
cycle to perform its multiple functions in catalysis [38].
Also the structure of a type II 3,6-diketocamphane monooxygenases (3,6-
DKCMO) from P. putida NCIMB 10007, has been solved using a noncrystallo-
23
1.3. Baeyer-Villiger Monooxygenases
graphic symmetry (NCM) study (pdb code 2WGK). The enzyme complex is a
trimer containing a NADH-dehydrogenase subunit and a homosymmeric FMN-
binding monooxygenase component [25].
1.3.5 Enzymes and cofactor regeneration
Baeyer-Villiger monooxygenases and more in general oxydoriductases are cofactor-
dependent enzymes because they require electrons to activate molecular oxygen.
In such enzymes electrons are provided by nicotinamide coenzymes (NAD(P)H).
The main drawback in the use of these cofactors is their high costs, limiting their
use in stoichiometric amount, so they have to be regenerated in situ for large-scale
applications. Many approaches have been developed to use this biomolecules in
a catalytic amount facilitating the use of isolated enzymes [22, 21, 110]. Some
important requirements are necessary for a good cofactor regeneration system.
The total torn over number (TTN), for example must be high enough to make the
regenerative process economically feasible (from 103 to 105) moreover, it reflects
several important factors such as concentration and degradation of the cofactor
over time, regioselectivity of regeneration, rate of catalysis, and time of reaction.
In addition the regeneration step has to be favourable from a kinetic and ther-
modynamic point of view and, reagents and by-products, preferably stable in the
process conditions, should not interfere with the whole system.
Enzymatic reactions are good candidates to be a regeneration system (Fig.
1.7). The most studied enzymatic methods have been developed for the regen-
eration of NAD(P)H, and involves mainly dehydrogenases such as formate de-
hydrogenase (FDH), glucose-6-phosphate dehydrogenase (G6PDH) [16], glucose
dehydrogenase (GDH) [115] alcohol dehydrogenase (ADH)) and the phosphite
dehydrogenase (PTDH) [112], the latter one was also used as fusion protein co-
valently linked to a BVMO to create a self-sufficient enzyme, able to perform the
Baeyer-Villiger oxidation and cofactor regeneration (Fig. 1.8) [79].
Chemical regeneration of nicotidamide cofactors provides the use of organome-
tallic-complex such as the rhodium complex [Cp∗Rh(bpy)(H2O)]2+ (Fig. 1.9)
[48]. Ottolina and co-workers utilized this complex for FAD regeneration in
BVMOs-mediated sulfoxidation but unfortunately the reaction conversion and
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Substrate1 Substrate1-H2
NAD(P)H NAD(P)+
Substrate2-H2Substrate2
Enzyme 1
Enzyme 2
cofactor regeneration enzyme
glucose + NAD(P)+ glucono-δ-lactone+ NAD(P)H + H+ gluconate
glucose dehydrogenase H2O
formate + NAD(P)+ CO2 + NAD(P)H + H+
formate dehydrogenase
alcohol + NAD(P)+ ketone + NAD(P)H + H+
alcohol dehydrogenase
phosphite + NAD(P)+ phosphate + NAD(P)H + H+
phosphite dehydrogenase
Figure 1.7: Enzymatic NAD(P)H cofactor recycling systems.
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Figure 1.8: Coenzyme regeneration by fusion enzyme.
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product e.e.’s were lower respect values obtained with the enzymatic regenera-
tion system (G6PDH).
Figure 1.9: Organorhodium complex [Cp∗Rh(bpy)(H2O)]2+ regeneration in BVMO-
catalyzed oxidation of sulfides.
The use of an electrode by direct or indirect reduction of NADP+ using re-
dox mediators is employed in electrochemical regeneration systems, additionally
redox-active enzymes can be use to shuttle electrons from electrode to the coen-
zyme (Fig. 1.10) [46].
Photochemical regeneration is a light-driven regeneration system in which
light can reduce FAD in the presence of an electron donor such as theethylene-
diaminetetraacetate (EDTA) or mercaptoethanol with a catalytic amount of
NADPH for the substrate tournover (Fig. 1.11) [47].
1.3.6 Whole-cells and large scale application of BVMOs
To avoid in situ cofactor regeneration systems is possible perform whole-cell
biooxidations using growing o resting cells. The organism expressing the BVMO
provides natural recycling system for all coenzymes. However, there are also some
disadvantages such as unwanted side reactions by competing enzymes or the fact
that substrate and product can be used by others proteins present in the cells,
mainly if the wild-type organism is utilized or if the enzyme is not overexpressed.
Another limitation in whole-cell biotransformations is the possible substrate or
product inhibition. Also for this reason SPRF (substrate feeding and product
removal process) were developed (Fig. 1.12).
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(StyA). Applied on a preparative scale, however, this complex
showed a relatively low specific activity (Hollmann et al., 2003a;
Lutz et al., 2004). Another organometallic-complex that can be
used for coenzyme regeneration is [RuCl2(TPPTS)2]2. This catalyst
uses hydrogen gas (H2) as sacrificial substrate and transfers its
electrons to the nicotinamide coenzyme. Notably, no by-product
is obtained as the substrate is fully incorporated in NAD(P)+.
This regeneration system has been shown to work with vari-
ous enzymes, e.g., the NADP+-dependent alcohol dehydrogenase
from Thermoanaerobiumbrockii. In the same study, it was shown
that the [Cp*Rh(bpy)(H2O)]2+-complex could also use H2 as elec-
tron donor for the regeneration of NAD(P)H (Wagenknecht et
al., 2003). However, the utilization of H2-gas for the regenera-
tion of NAD(P)H in monooxygenase-catalyzed reactions is out of
question, as the addition of O2 would lead to extremely haz-
ardous situations. It is therefore quite obvious that no studies
have been performed on monooxygenases using H2 as electron
donor.
Studies of coenzyme regeneration with simple chemical reduc-
ing agents such as dithionite have thus far not been very successful.
This is mainly due to the fact that such reducers lack the ability
to specifically reduce NAD(P)+ to the enzymatically active 1,4-
NAD(P)H isomer (Hollmann et al., 2006).
3.2. Electrochemical regeneration
The employment of electrode surfaces for the electrochem-
ical regeneration of NAD(P)H is considered to be a powerful
regeneration method with advantages ranging from the low
cost of electricity to easy product isolation. Initial technolog-
ical complications such as electrode fouling, requirement of a
high overpotential and the fact that the biocatalyst is only active
in the vicinity of the electrode have been addressed. Modifica-
tions of the electrode surface have resulted in less fouling and
the requirement of overpotentials can be reduced by application
of mediators such as viologens and [Cp*Rh(bpy)(H2O)]2+. Elec-
Fig. 9. Available methods for electrochemical regeneration of NAD(P)H (Hollmann and Schmid, 2004).
Figure 1.10: Available methods for electrochemical regeneration of NAD(P)H. (Im-
age from http://dx.doi.org/10.1016/j.jbiotec.2010.01.021)
Figure 1.11: Light reduction of FAD in the presence of ethylenediaminetetraacetate.
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The industrial applicability of the Baeyer-Villiger oxidation, was demon-
strated with the first kilogram scale-up of asymmetric whole-cell bioconversion of
the racemic bicyclo[3.2.0]hept-2-en-6-one, using a “resin-based in-situ substrate
feeding and product removal” methodology (in situ SFPR). Substrate ketone
and product lactone were adsorbed into a resin, which acts as a reservoir, allow-
ing slow realise of substrate and at the same time continuous removal of formed
product and maintaining both the substrate and product concentration below
the inhibitory level. In such as system oxygen transfer is a critical factor. Using
specially designed bubble column reactor, oxygenation of medium can be easily
improved [44]. Down streaming process consists in a simply extraction of lac-
tones from the resin, making it reusable. This technology gives the possibility to
avoid some limitations such as substrate/product solubility and inhibition with
a simplified downstream process.
Resin 
Ketone 
desorption 
Lactone(s) adsorption 
air 
O2 
mass transfer 
Cell O2 
H2O CHMO 
NADPH 
NADP(+) 
Figure 1.12: Principle of a microbial Baeyer-Villiger oxidation using a resin-based in
situ SFPR strategy.
Using optimal conditions is possible to run a 900 g scale experiment, using
a 50 L reactor at a substrate concentration of about 25 g/L. This reactor thus
provided a volumetric productivity as high as 1.02 g lactones/L/h (136 U/L)
[45].
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1.3.7 Synthetic applications
Desymmetrization reactions are important applications of enzymatic Baeyer-
Villiger oxidation in organic chemistry. Desymmetrization consists in the in-
troduction of chirality into a symmetric element converting a prochiral pre-
cursor in a theoretically 100% yield of pure chiral product. Biooxidation of
prochiral functionalized cyclohexanones and cyclobutanones is a good exemple
of desymmetrization with high stereoselectivity. Also desymmetrization of fused
bicycloketones were investigated, in particular Mihovilovic et al. have anal-
ysed the enantiocomplementary lactones produced by some representatives BV-
MOs observing a relevant clustering into two groups, CHMO-type and CPMO-
type BVMOs, the first subclass give both lactones, the second one give the
antipodal products with moderate to excellent enantiomeric excess [76]. An
appealing application of BVMOs in desymmetrization processes is the synthe-
sis of R-baclofen, a derivative of gamma-aminobutyric acid (GABA), acting
as agonist for the GABAB receptors [71]. It can be prepared from the 3-(p-
chlorophenyl)-γ-butyrolactone in excellent optical purity from biotransforma-
tions utilizing wild-type cells of Cunninghamella. Using the same strain 3-
(benzyloxymethyl)-cyclobutanone can be oxidized to another active intermedi-
ate, the (R)-(–)-γ-buryrolactone, which is transformed via stereodivergent syn-
thesis in (R,S)-β-proline [71]. All these compounds are interesting from a phar-
maceutical point of view.
Figure 1.13: Biooxidation to butyrolactones of relevance in total synthesis.
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Kinetic resolution is another relevant application of BVMOs. Starting from
a racemate material and a chiral agent, a kinetic preference of one enantiomer
over to the other is achieved, the 50% of the starting material is converted to the
enantiopure product and the other half is lost. Several synthetically interesting
substrates derived from functionalized cycloketones were used in kinetic reso-
lution and the corresponding products were used as key-precursor for another
transformation (Fig. 1.14).
Figure 1.14: Application of chiral compounds obtained upon kinetic resolution of
α-substituted ketones in bioactive compound synthesis.
An improvement to kinetic resolution in term of product yield is the develop-
ment of a dynamic process. In dynamic kinetic resolution (DKR) epimerization
and resolution occur simultaneously leading to 100% yield of the desired com-
pound. The first example of DKR by BVMOs was for a benzyloxy-ketone in
which the substrate was racemized at elevated pH within a whole-cell biotrans-
formation giving 86% yield of (R)-lactone in 96% e.e. [11].
Another appealing synthetic application is the radiodivergent BVMO-mediated
biotrasformation. In the conversion of racemic bicyclo[3.2.0]hept-2-en-6-one four
possible products are obtainable (Fig. 1.16), two regioisomeric lactones, the ex-
pected “normal” and the unexpected “abnormal” according to the migratory
preference of the higher substituted carbon center and two enantiomers of each.
The bioconversion of such racemic substrate by CHMO from Acinetobacter
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Figure 1.15: Dynamic kinetic resolution of ketone 83 by recombinant whole cells.
Figure 1.16: Radiodivergent biooxidation of racemic bicyclo[3.2.0]hept-2-en-6-one.
gives an equimolar mixture of “normal” as well as “abnormal” lactone in a excel-
lent enantiomeric excess, the “normal” one is used as a precursor for a building
block in the synthesis of prostaglandins [1]. The “abnormal” regioisomer is used
as a starting material for the chemoenzymatic synthesis of a series of brown algal
pheromones (multifidene, viridene, caudoxirene) and for the cytostatic drug (R)-
(–)-sarkomycin. C. echniulata NRRL 3655 only produces the latter unexpected
lactone (ratio 0:1) in a kinetic resolution process [61, 62]. The reason of these
radiodivergence is probably due to the different position in the active site of each
antipodal substrates and then different groups are situated antiperiplanar to the
O-O bond in Criegee intermediate [73]. As for desymmetriation reactions sev-
eral BVMOs were compared in the biooxidation of fused bicycles suggesting the
same clustering; CHMO-type produces an equimolar amount of the two antipo-
dal lactones in high enantioselectivity, CPMO-type yields mainly the expected
“normal” lactones with low enantioselectivity.
Bayer-Villiger monooxygenases are also able to perform oxidation of het-
eroatoms (sulfur, nitrogen, phosphorus, boron, selenium) and even epoxidation
reactions [84, 20, 15]. In particular asymmetric sulfoxidation seems to be the
most appealing because chiral sulfoxides are valuable building block for the syn-
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thesis of biologically active compounds. PAMO and others type I BVMOs (e.g.
CHMO, HAPMO) have shown high enantioselectivity towards alkyl aryl sul-
phides, dialkyl sulphides and cyclic and acyclic 1,3 dithioacetals.
Figure 1.17: Sulfoxidations BVMO-catalyzed.
We have already mentioned some example of pharmaceutical active ingre-
dients and intermediates available by Baeyer-Villiger monooxygenases, such as
production of (R)-lipoic acid and or the synthesis of the cytostatic drug (R)-(–)-
sarkomycin. Another important potential application of BVMOs is the synthesis
of β-amino acids used as building block for the preparation of β-peptides, alka-
loids, terpenoids and β-lactam antibiotics. The reaction involves is the oxidation
of linear aliphatic ketones possessing an amino group in the β position. In a ki-
netic resolution process, amino β-ketones were used as racemic substrates leading
to an enriched N-protected β-amino ester, then hydrolysed to obtain optically
pure N-protected β-amino acid and N-protected β-amino alcohol depending on
the regioselectivity of the biocatalyst [87, 88].
Figure 1.18: Enzymatic synthesis of β-leucine precursor.
1.4 Goals and Outline of the Thesis
The Baeyer-Villiger reaction, consisting in the production of esters or lactones
starting from ketones, is considered a powerful oxidation in organic synthesis
because of the cleavage of C-C bonds with the concomitant insertion of an oxy-
gen atom, which is since a long time a big challenge for chemists. The clas-
sical approach to perform this reaction involves the use of hazardous oxidizing
agents such as peroxyacids, very reactive compounds lacking the high chemo-,
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region- and enantioselectivity expected in organic synthesis. Biocatalysis repre-
sents an alternative tool to carry out chemical transformations with an environ-
mental friendly methodology. In this context, Baeyer-Villiger monooxygenases
are “green” catalysts able to catalyse the Baeyer-Villiger reaction as natural
equivalents of peroxyacids. BVMOs are flavin-dependent monooxygenases us-
ing NAD(P)H as electron donor and not-covalently bound FMN and FAD as
prosthetic group. In particular Type I BVMOs, which use NADPH and FAD
as cofactors and are the best widespread and characterized enzymes, seems to
have great potential for synthetic applications. In general BVMOs have been
identified in a large number of bacteria and fungi but only a restricted number
of them are available in recombinant form.
The goal of the project was discover novel type I BVMOs to enlarge the tool-
box of new recombinant biocatalysts able to perform oxidation reaction towards
molecule of potential pharmaceutical interest. In order to discover novel type I
BVMOs, new sources of enzymes have been explored.
A report on known Baeyer-Villiger Monooxygenases as recombinant biocata-
lysts is described in Chapter 2. This chapter provides an overview concerning
the occurrence and metabolic role of known BVMOs in nature and the discov-
ery of new type I BVMOs from unusual sources using genome-mining approach.
In fact we have identified and selected five new putative BVMOs from different
organisms: Oryza sativa (Os; plant), Physcomitrella patens (Pp; moss), Cyani-
dioschyzon merolae (Cm; red alga), Trichodesmium erythraeum (Te; cyanobac-
terium), Haloterrigena turkmenica (Ht; archeabacterium). In particular, basing
on most updated literature, the photosynthetic eukaryotes Oryza, Physcomitrella
and Cyanidioschyzon would result very uncommon sources for BVMOs.
In Chapter 3 is reported a detailed description concerning the cloning and
the heterologous protein expression in E. coli used for each putative sequence.
The low solubility of the expressed proteins was the main bottleneck of the
work; many strategies were adopted to obtain some soluble proteins. Addition
of riboflavin to growth medium was successful to obtain soluble flavoproteins from
Physcomitrella patens and Cyanidioschyzon merolae, showing the importance of
the flavin cofactor in the folding process.
Chapter 4 illustrates the biocatalytic characterization of the two flavopro-
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teins. It has been carried out at the Biotransformation and Biocatalysis group
of Prof. Dr. M.W. Fraaije (University of Groningen, The Netherlands), a main
expert concerning flavoenzymes and in particular in Baeyer-Villiger monooxy-
genases. Optimization of reaction conditions (pH and Temperature optimum
and stability) was determined and after a substrate screening assays, a detailed
steady-state study on the three enzymes was reported.
In Chapter 5 the work described in this thesis is summarized, discussed and
some future perspectives are mentioned.
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Chapter 2
Discovering New BVMOs
Abstract:
Baeyer-Villiger monooxygenases (BVMOs) are an interesting and versatile class of
flavoenzymes NADPH-dependent able to catalyse a remarkable wide variety of oxida-
tive reactions, which are difficult to be obtained chemically [35, 73]. Up to the last ten
years, a few BVMOs have been cloned and overexpressed. The number of recombinant
BVMOs is considerably increased because of the vast genetic information available
from genome sequencing. In particular, genome mining has proven to be an efficient
approach to discover new biocatalysts. This chapter provides an overview concerning
the occurrence and metabolic role of known BVMOs in nature and the discovery of
new ones from unusual sources.
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2.1 Occurrence and metabolic role of known BV-
MOs
The first BVMO purified was in 1965 by Conrad H.E. et al., while studying the
camphor lactonization system occurring in Pseudomonas sp. [26]. However, the
first indication of a Bayer-Villiger oxidation activity was found in the late 1940s:
it was involved in the microbiological degradation of steroids, in particular the
conversion of progesterone to testolactone in Penicillum species and Aspergiullus
flavus [109]. Hereafter, it has been found that many BVMOs play an important
role in the degradative metabolism of bacteria and fungi. The first discovered
enzymes have been the cyclohexanone monooxygenases (CHMO) from Acineto-
bacter calcoaceticu and Pseudomonas putida. Within a few years several from
then new type I BVMOs were overexpressed in E. coli and characterized (Tab.
2.1). They included several cyclohexanone monooxygenases (CHMOs), a steroid
monooxygenase (STMO) acting on steroids, a cyclopentanone monooxygenase
(CPMO) that modifies smaller ring systems, a cyclododecanone monooxyge-
nase (CDMO) and cyclopendadecanone monooxygenases (CPDMO) acting on
larger cyclic compounds. Additionally, 4-hydroxyacetophenone monooxygenases
(HAPMO) and phenylacetone monooxygenases (PAMO) accept aromatic ketones
and phenylacetone derivatives.
2.1.1 Cyclohexanone monooxygenase (CHMO)
In 1976 Trudgill et al. reported the isolation and characterization of the Type I
BVMO cyclohexanone monooxygenase (CHMO) from Acinetobacter sp. NCBI
9871 (E.C. 1.14.13.22), responsible for the biodegradation of cyclohexanol to cy-
clohexanone (Fig. 2.1). Besides cyclohexanone, the enzyme was able to catalyze
the oxidation of a vast variety of cyclic ketones making it potentially interesting
for synthetic purposes [108]. The substrates list included cyclic, bicyclic and
heterocyclic ketones with a lot of substituents [75]. The extraordinary char-
acteristic of CHMO is its high chemo-, regio-, enantioselectivity toward more
than 100 substrates; it also oxidizes enantioselectively a wide range of sulfides
[?], tertiary, secondary and hydroxyl amines [24]. This enzyme was found as-
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sociated with other enzymes involved in the fatty acid beta-oxidation pathway,
where the Bayer-Villiger oxidation is the second step after the conversion of
the cyclohexanol to cyclohexanone. ChnC, the gene flanking the one coding for
CHMO, encodes a caprolactone hydrolase able to hydrolase the produced lactone.
Such a monooxygenase-hydrolase gene localization (linked position) has been
found also for others genome fragments containing BVMOs genes (i.e. cyclopen-
tanone monooxygenases, pheylacetone monooxygenases, 4-hydroxyacetophenone
monooxygenase and cyclopentadecanone genes.
Figure 2.1: Role of CHMO from Acinetobacter sp. NCIMB 9871 in the catabolic
degradation of cyclohexanol. (Image from Chem Rev. 2011 Jul 13;111(7):4165-222.
doi: 10.1021/cr1003437)
2.1.2 Cyclopentanone monooxygenase (CPMO)
Cyclopentanone monooxygenase from Pseudomonas sp. NCIMB 9872, reclas-
sified as Comamonas in the same year, is responsible for the degradation of
cyclopentanol or cyclopentanone [50, 41]. The Baeyer-Villiger oxidation is the
second step of the pathway and consists in the conversion of cyclopentanone to
5-valerolactone (Fig. 2.2).
Sequence analysis revealed a cluster of genes and six potential open reading
frames grouped in 4 possible transcriptional units [50] The cpnABCDE genes
encode for the five enzymes catalyzing the five steps of the conversion of cy-
clopentanol to glutaric acid (Fig. 2.3).
The protein sequence of CPMO is 37% identical to the CHMO of Acineto-
bacter strain NCIMB 9871, but the best score given by BLAST search was the
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Figure 2.2: Degradation pathway for cyclopentanol by Comamonas sp. strain
NCIMB 9872.
orf!""! orf!"#! orf!$! cpn!%! cpn &! orf!'! cpn!!(! cpn!!)! cpn!!*! cpn!!+! orf!!,! orf!!-!
Figure 2.3: Cpn gene cluster organization in Comamonas sp. strain NCIMB 9872.
CHMO2 of Brevibacterium sp. Strain HCU, with 49,5% of identity [49]. The
recombinant protein, available from 2002, is able to oxidize several cyclic ke-
tones, but it may also transform aromatic and conjugated ketones not accepted
by CHMO. Regarding its selectivity, CPMO results quite similar to CHMO, but
many examples of enantio- and regiodivergent transformations were reported
[113]. Comparative biocatalytic studies have revealed that CHMO from Acinet-
bacter and CPMO from Comanonas can be considered as models for two BVMO
subclasses, the CHMO-type and CPMO-type groups [76].
2.1.3 4-Hydroxyacetophenone monooxygenase (HAPMO)
The Baeyer-Villiger oxidation has been detected also in the microbial degrada-
tion of aryl ketones, in particular ring-substituted acetophenones [29, 42]. Pseu-
domonas fluorescens ABC is able to grow on 4-hydroxyacetophenone as carbon
source [43]: it produces a Baeyer-Villiger monooxygenases (HAPMO) that was
isolated and purified in 1999,. The gene cluster hapCDEFGHIBA of this organ-
ism, involved in the 4-hydroxyacetophenone degradation, was cloned and anal-
ysed: it encodes five enzymes and others regulatory proteins. The first two reac-
tions of the whole transformation are catalyzed by the monooxygenases (HapE)
and an esterase (HapD); the formed hydroquinone is cleaved by a dioxygenase
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(HapC) producing a 3-hydroxymuconic semialdehyde, oxidized to maleylacetate
by HpA and then reduced to β-oxoadipate by HapB (Fig. 2.4).
Figure 2.4: Baeyer-Villiger reaction observed during microbial degradation of aro-
matic compounds in Pseudomonas fluorescens ABC.
hap!"! hap!#! hap!$! hap!%! hap!&! hap!'!!!!hap!(!!!! hap!)!!!!! hap!*! hap!+,!
Figure 2.5: Organization of hap gene cluster of P. fluorescens.
4-hydroxyacetophenone monooxygenase (hapA), 4-hydroxyphenyl acetate hy-
drolase (hapB), HQDO (HapD), 4-hydroxymuconic semialdehyde dehydrogenase
(hapE), and maleylacetate reductase (hapF) genes. The enzyme HAPMO, over-
expressed in E. coli and characterized in 2001, has great substrate specificity
and accepts heteroaromatic ketones, aliphatic ketones and sulfides [55]. More-
over, HPMO is a homodimer strictly dependent on NADPH and structurally
different from others type I BVMO because of the presence of a 135 amino acid
N-terminal extension playing an important role in stabilizing the HAMPO dimer.
A HAPMO-homologue from Pseudomonas putida JD1, an organism able to grow
on 4-etyilphenol which is degraded via 4-hydroxyacetophenone. was purified and
characterized in 2000 [103].
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2.1.4 Steroid monooxygenase (STMO)
As previously mentioned, the first indication of a Bayer-Villiger oxidation ac-
tivity was found in the microbiological degradation of steroids (Fig 2.6). The
steroid monooxygenases from the bacterium Rhodococcus rhodochrous catalyze
the oxidation of progesterone side-chain to the testosterone acetate. The unique
enzyme from the fungus Cylindrocarpon ridicicola ATCC 1101, is able to per-
form the bifunctional oxidation of progesterone to testosterone acetate and of
androstenedione to testolactone.
Figure 2.6: Metabolic pathway of progesterone in fungi.
This enzyme shows a high sequence homology with the well-known BVMOs,
53% sequence identity with PAMO from Thermobifida fusca, 45% with CHMO
from Rhodococcus sp. strain HI-31, and 43% with OTEMO from Pseudomonas
putida. It has been expressed in recombinant form in E. coli and has exhibited a
diverse substrate preference ranging from a simple aromatic (phenylacetone) to
a steroid molecule [38].
2.1.5 Cyclododecanone monooxygenase (CDMO)
The enzyme cyclododecanone monooxygenase was found in a strain able to de-
grade large cyclic hydrocarbons as Rhodococcus ruber CD4 and was purified and
characterized. The coding gene (cddA) from Rhodococcus ruber SC1 was cloned
and expressed in E. coli, resulting able to convert his natural substrate cyclodo-
decanone into lauryl lactone and more in general C11-C15 cyclic ketones (Fig.
2.7).
The gene is grouped in a cluster with five other genes (Fig. 2.8): the first
two genes, cddA and cddB, encode the enzymes catalysing the first two steps of
the cyclododecanone oxidation. The last two genes, cddC and cddD, encode the
two dehydrogenases necessary for oxidation of 12-hydroxylauric acid to generate
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Figure 2.7: Biochemical degradation of cyclododecanone by Rhodococcus ruber SC1.
dodecanedionic acid. The two central open reading frames (ORFS), cddX and
cddY, encode proteins of unknown function [58].
cdd !" cdd #" cdd $" cdd %" cdd &" cdd '"
Figure 2.8: cdd gene cluster organization in Rhodococcus ruber SC1.
2.1.6 Phenylacetone monooxygenase (PAMO)
Differently from others BVMOs obtained by culturing a specific microorganism,
the termostable phenylacetone monooxygenases (PAMO), from the termophilic
actinomycete Termobifida fusca, was discovered by genome mining using the de-
scribed “fingerprint” motif characterizing type I BVMOs. Two putative BVMO
genes were identified, but only one of them shows relatively high sequence iden-
tities with known BVMOs, 53% with steroid monooxygenases and 40% with
cyclohexanone monooxygenases. The purified recombinant enzyme was able to
oxidize a wide range of carbonylic compounds in particular aromatic and aliphatic
ketones and organic sulphides [37]. By genome analysis, genes flanking the pamo
gene sequence were also investigated; they code for an alcohol dehydrogenase, a
reductase and an esterase. The latter enzyme, in combination with the others
simultaneously expressed, suggests their involvement in some degradation path-
way, as for many other BVMOs. PAMO is also the first BVMO for which the
X-ray structure has been solved [69].
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2.1.7 Cyclopentadecanone monooxygenase (CPDMO)
Another enzyme able to accept large (C15) and small (C6) cyclic and bicyclic
ketones is cyclopentadecanone monooxygenase. Naturally derived from Pseu-
domonas sp. strain HI-70, it has been expressed in E. coli. In 2009 Beneventi
et al. showed that it was able to oxidize numerous 3 and 17-ketosteroids with
a full control of the regiochemistry of the produced lactones, enlarging the sub-
strate scope of the CPDMO to more demanding molecules such as steroids [10].
In the genome of Pseudomonas sp. strain HI-70, the gene coding for cyclopen-
tadecanone monooxygenases (cpdB), is located in between two genes, encoding
a transcriptional regulator (cpdR) and, a lactone hydrolase (cpdC ) (Fig. 2.9).
cpdR! cpdB! cpdC!
Figure 2.9: cpdB gene localization in Pseudomonas sp. strain HI-70.
2.1.8 Ethionamide monooxygenase (EtaA)
Ethionamide is a thioamide precursor of antitubercular prodrugs and having
a lethal effect if oxidatively activated by the protein EtaA, a type I Baeyer-
Villiger monooxygenase acting as a prodrug activator and found in Mycobac-
terium tuberculosis. The EtaA gene sequence contains the “fingerprint” motif
typical of BVMOs and the closest homolog is 4-hydroxyacetophenone monooxy-
genase (HAPMO), with which it displays 24% of identity. The enzyme converts
a wide range of ketones, in particular long-chain ketones (e.g. 2-hexanone and
2-dodecanone), but also aromatic ketones (phenylacetone and benzylacetone)
are converted. EtaA is also able to catalyze enantioselective sulfoxidation of
methyl-ptolylsulfide [36].
2.1.9 Camphor degradation
(2,5-3,6-DKCMO and OTEMO)
The first BVMO identified in the bio oxidative degradation of camphor (Fig. 2.9)
was the 2,5-diketocamphane 1,2-monooxygenase (2,5-DKCMO). After an oxida-
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tive cascade drived by P450 complex, the (+)-camphor (+1) is transformed into
the 2,5-diketocamphane (3), oxidized by the 2,5-diketocamphane monooxygenase
(a) (2,5-DKCMO), an NADH dependent enzyme containing FMN [106]. (–)-
Camphor (–1) is metabolized by the isofunctional enzyme 3,6-diketocamphane
1,6-monooxygenase (b) (3,6-DKCMO) [52]. Both proteins are type II BVMOs.
Figure 2.10: Degradative pathway of camphor.
Both resulting lactones formed are instable and undergo spontaneous forma-
tion of 2-oxo-∆3-4,5,5-trimethylcylopentenylaceticacid, which Co-A activated (4)
is the substrate of the 2-oxo-∆3-4,5,5-trimethylcylopentenylacetyl-CoA monooxy-
genase (c)(OTEMO), a type I BVMO.
cam
C!
cam
D!
cam
R!
hidrolase!TetR-
type!
DKCMO!OTEMO!topo!
Figure 2.11: Localizations of the OTEMO-encoding gene in P. putida ATCC 17453.
The identified open reading frames are as follows, from left to right: putative DNA
topoisomerase III (topo), OTEMO, 2,5-diketocamphane monooxygenase (DKCMO),
aTetR-type regulator, lactone hydrolase, and a camR repressor.
2.1.10 Monocyclic monoterpene ketone monooxygenase
(MMKMO)
In contrast to the bicyclic monoterpene camphor degradation pathway, which in-
volves three BVMOs, monocyclic monoterpene ketone monooxygenase (MMKMO)
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is the only type I BVMO purified from Rhodococcus erythropolis DCL14, impli-
cated in degradation pathways of many monocyclic monoterpenes, i.e. limonene,
(dihydro)carveol and menthol [31].
Figure 2.12: Reactions catalysed by MMKMO from R. erythropolis DCL14.
MMKMO has a broad substrate specificity, catalysing the lactonization of
a large number of monocyclic monoterpene ketones and substituted cyclohex-
anones; aldehydes and acyclic ketones did not act as substrates. The regiospeci-
ficity of the enzyme depends on the diasteroisomer used as the substrate (compare
dihydrocarvone with iso-dihydrocarvone) (Fig. 2.12).
2.1.11 Exploring novel putative type I BVMOs
The classical approach for discovering new enzymes has been the culture of mi-
croorganisms showing a specific activity, and then the rescue of the gene of
interest through cloning. This time-consuming method was used for many years
and has been successful to obtain most of the best-known BVMOs. However,
up to 99% of bacteria in the environment are not readily cultured in the lab [?],
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especially extremophile microorganisms. In this way, most of the novel potential
enzyme activities result unavailable.
Advances in molecular biology techniques and genomics have laid the basis
for the development of other interesting approaches for enzyme discovery. In
fact, the rapid increasing of sequence information in public databases and the
parallel development of bioinformatics have opened the route to the so called “in
silico genome mining” approach. By homology alignment a BLAST-search can
find conserved regions between sequences. Well-known enzymes with desired
properties, preliminarily chosen as probes, are needed. Usually the sequences
with moderate identity are selected as candidates [65]. In earlier studies searches
performed by genome mining showed that type I BVMOs were present in a vast
variety of bacteria and fungi, but not in Archea, plants or human genomes [54].
In order to enlarge the possibility to find out novel and promising biocata-
lysts, we used the genome mining approach to “hunt” BVMOs within specific
and unusual organisms. Using as template PAMO and the “fingerprint” motif
of type I BVMOs (FxGxxxHxxxWP/D) as discriminant, we have identified and
selected five new putative BVMOs from five different organisms: Oryza sativa
(Os; plant), Physcomitrella patens (Pp; moss), Cyanidioschyzon merolae (Cm;
red alga), Trichodesmium erythraeum (Te; cyanobacterium), Haloterrigena turk-
menica (Ht; archeabacterium). In particular, basing on most updated literature,
the photosynthetic eukaryotes Oryza, Physcomitrella and Cyanidioschyzon would
result very uncommon sources for BVMOs.
2.1.12 New putative type I BVMOs from prokaryotic or-
ganisms
It has been known for long time that many bacteria and fungi produce Baeyer-
Villiger enzymes but until 1990s only few of these enzymes were isolated, purified
and characterized. [101] Today, almost all of the available recombinant BVMOs
are type I enzymes that require NADPH and FAD as cofactors. Thanks to
the identification by genome mining, the collection of BVMOs is growing fast.
In particular, we have identified two new putative BVMOs from recently se-
quenced prokaryotic organisms, Trichodesmium erythraeum and Haloterrigena
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turkmenica.
Trichodesmium erythraeum IMS101 is a filamentous cyanobacterium and is
a species of Trichodesmium genus also called “sea sawdust”, founded in nutri-
ent poor tropical and subtropical ocean waters. It fixes atmospheric nitrogen
into ammonium using photosynthesis [19]. The complete sequence of its genome
appeared in 2006 (http://www.jgi.doe.gov). The primary structure of the protein
annotated as “probable flavin-binding monooxygenase” (protein id=ABG52868.1,
locus tag=Tery 3824) is consists of 493 residues with 43% sequence identity to
PAMO and 37% to CHMO.
Haloterrigena turkmenica DSM 5511 is an extremely halophilic archeon iso-
lated from a sulphate saline soil in Turkmenistan. The plasmid pHTUR01 en-
codes a protein “similar to cyclohexanone monooxygenase” (protein id=ADB62698.1,
locus tag=Htur 3838): its 554 residues long sequence is 50% identical to PAMO
and 43% to CHMO from Acinetobacter. No BVMOs have been identified so far
in archea genomes.
2.1.13 New putative type I BVMOs from eukaryotic or-
ganisms
Up to last year, all the available recombinant BVMOs were from prokaryotic
origin. The first eukaryotic BVMO cloned and expressed in E. coli is cycloal-
kalone monooxygenases from the ascomycete Clyndrocarpon radicicola ATCC
11011 (identical to Cylindrocarpon destructans DSM 837). This enzyme is able
to convert progesterone via androstenedione towards ∆1-dehydrotestololactone
[63]. Before the publication of this very recent discovery, we had begun our re-
search with the aim of identifying new BVMOs. In particular, we had identified
by genome mining and then selected new putative enzymes from three photo-
synthetic eukaryotes: Cyanidioschizon merolae, Phiscomitrella patens and Oryza
sativa. The complete genomic sequences of the two former organisms were re-
spectively released in 2004 [70] and 2008 [89]. For the latter organism, a very
wide collection of cDNA sequences was deposited in 2003 [39]. The primitive
red algae Cyanidioschizon merolae is a unicellular organism living in acidic en-
vironments (like hot springs), even at pH < 2 and temperature of 45◦C. The
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putative enzyme is coded by an open reading frame present in chromosome 12
of the organism genome and its primary structure has 43% sequence identity to
PAMO.
Phiscomitrella patens is a moss, classified as a no vascular plant because it
differs from “higher” plants by not having internal vessels. From an evolution-
ary point of view, P. patens is situated between water and land plants: thus, it
has become a model organism for studies on plant evolution and developmental
physiology. In addition, it is increasingly used in biotechnology since it can be
efficiently transformed and is able to integrate exogenous DNA by homologous
recombination [94]. The 536-residue primary structure of the identified hypothet-
ical protein from P. patens reveals 54% sequence identity to PAMO and 37% to
CHMO Rhodococcus sp. Phi1. Differently from those, however, the BVMO “fin-
gerprint” motif is not perfecltly respected in the protein from the moss, being
FxGxxxYxxxWP instead of FxGxxxHxxxWP. It is worth noting that the central
histidine of the motif (His-173 in PAMO) is crucial for both FAD binding and
catalysis.
Oryza sativa is a plant commonly known as Asian rice. It is relatively easy to
be genetically modified and it is used as model organism for cereal biology. The
putative enzyme that we selected correspond to the translation of a full-length
cDNA clone from Oryza sativa Japonica Group rice (GenBank: AK107233.1):
its amino acid sequence reveals 39% identity to PAMO and 32% to CHMO.
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Abstract:
Type I Bayer-Villiger monooxygenases are FAD-containing, NADPH dependent oxida-
tive enzymes sharing, besides common biochemical properties, the conserved “finger-
print” motif FxGxxxHxxxWP/D. This BVMO-specific sequence was used to compare
BVMO sequences in genomic databases trying to found out novel BVMOs. Till now,
all identified BVMO genes come from bacteria or fungi, but not from Archea, plant
or human genomes. In order to enlarge the possibility to find out new and promising
biocatalysts, we used the genome mining approach to “hunt” BVMOs within genomes
of unusual organisms. By this way we have identified and selected five new putative
BVMOs from five different organisms: Oryza sativa (Os; plant), Physcomitrella patens
(Pp; moss), Cyanidioschyzon merolae (Cm; red alga), Trichodesmium erythraeum (Te;
cyanobacterium), Haloterrigena turkmenica (Ht; archibacterium). In particular, bas-
ing on most updated literature, the photosynthetic eukaryotes Oryza, Physcomitrella
and Cyanidioschyzon would result very uncommon sources for BVMOs. This chapter
gives a detailed description concerning cloning and heterologous protein expression in
E. coli used for each putative enzyme.
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3.1 Cloning and expression strategy
To obtain the desired putative recombinant proteins, a suitable expression sys-
tem had to be generated. To facilitate this work, we decided to use the same
cloning strategy for all the five sequences. The expression vectors were created
by digestion of pET-28a(+) with NcoI/NotI and ligation of the amplified Ht-
BVMO, Te-BVMO, Os-BVMO, Cm-BVMO, Pp-BVMO sequences, cut by the
same enzymes. These sequences were obtained by two subsequent PCR reactions,
the first one producing a preliminary amplimer, which was then used for the sec-
ond mutagenic amplification. The latter PCR introduce proper restriction sites
through nested primers. The only difference among the five sequences was the
template material: genomic DNA for Te-BVMO, Cm-BVMO, Pp-BVMO and
plasmid DNA for Ht-BVMO and Os-BVMO (Fig. 3.1). Plasmid pET28a (+),
which carries the T7 promoter, the kanamycin resistance gene, and permits to
add a hexahistidine coding sequence tail at the cloned ORF was used as expres-
sion vector (Fig. 3.2). To transcribe the cloned sequence the T7 RNA polymerase
must be present. The host cells for this expression system are usually those of
the E. coli strain BL21 (DE3), having the gene for T7 RNA polymerase stably
integrated in its genome and controlled by the inducible promoter lac. Thus,
the obtained constructs were transformed in E. coli BL21 (DE3) and expression
tests were performed: in order to select better conditions for obtaining soluble
proteins, parameters such as temperature for expression, IPTG concentration
and suitable strain were varied.
3.2 Os-BVMO: Putative type I BVMO from
Oryza sativa
Oryza sativa is a plant specie (Fig. 3.3 and Fig. 3.4) commonly known as
Asian rice. Is a monocot and it has become a model system of genome research
for cereal plants, being favourable to genetic modification. Two sub-species of
O. sativa have been sequenced; the sticky, short-grained japonica group usually
cultivated in dry fields of East, Southeast Asia and Japan and, the nonsticky,
long-grained indica group, cultivated mostly submerged in tropical Asia and
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Figure 3.1: Cloning strategy scheme.
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Philippines [82]. Another sub specie is the broad-grained javanica growing in
tropical areas. The variety used in this work was the spp. japonica. The O.
sativa L. ssp. japonica genome was sequenced in 2002 and published in 2005
by International Rice Genome Sequencing Consortium (IRGSP) because of its
major importance in the world food industry. Its genome is the smallest one,
estimated at just 430Mb across 12 chromosomes (IRGSP 2005).
Figure 3.3: Oryza sativa spp japonica (Image from Genoscope,
http://www.genoscope.cns.fr).
Kingdom: Plantae 
Division: Angiosperms 
Class: Monocots 
Order: Poales 
Family: Poaceae 
Genus: Oryza 
Species: O. sativa !
Figure 3.4: Taxonomic classification of Oryza sativa.
3.2.1 Cloning of Os-BVMO
The cDNA of the putative gene Os-BVMO was present in a clone library (Mi-
crobial Culture Collection-NIES) of over 28,000 cDNA clones from japonica rice,
collected by a research team of the National Institute of Agrobiological Sci-
ences, Japan (Rice Full-Length cDNA Consortium, 2003). The purchased plas-
mid pCMVFL3 is a pCMVSport6 vector containing the cDNA of the putative
BVMO. We used as DNA template a fragment of the plasmid obtained from a
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first PCR reaction using the universal sp6 e T7 primers, annealing to the se-
quences of the plasmid flanking the Os-BVMO coding region. The 2000pb long
amplicon obtained was used for a second mutagenic PCR amplification driven
by the nested Os1 forward and Os2 reverse primers (Fig. 3.5). The two ampli-
fication steps and accurate optimization of annealing temperature was needed
because of the number of subsequent mismatches present in the Os1 primer. To
find the optimum temperature, PCR reaction tests with a temperature gradient
were performed. The annealing temperature found was 52◦C, quite low if com-
pared to the theoretical one of 68◦C. The PCR product obtained was the correct
DNA fragment of 1641 pb (Fig. 3.5).
!"!!!!#$%& !!!!"!!!!!#$%'!
Figure 3.5: 1% agarose gel analysis of the preliminary 2000 bp and final 1641 bp
PCR products (PCR1 and PCR2). M: standard marker (Promega).
Afterwards, a restriction digestion using both NcoI/NotI was performed to
prepare the insert for the ligation into pET28a. The resulting ligation product
was used to transform chemically competent XL1-Blue cells. Successful ligation
was examined by colony PCR and analytical restriction digestion (Fig. 3.6). .
3.2.2 Expression of Os-BVMO
After transformation into the suitable BL21(DE3) cells, pre-cultures were grown
overnight and used to inoculate a main culture for expression. Overexpression
tests were performed in order to find out better conditions for expression. Dif-
ferent growth temperatures (18, 30 and 37◦C) and different times for induction
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Figure 3.6: (A) 1% agarose gel analysis of amplimers produced by colony PCR.
(B) 1% agarose gel analysis of a positive recombinant plasmid pET28a-Os-BVMO by
restriction digestion using NcoI/NotI. M: standard marker (Promega).
were checked. Final cell samples were also disrupted by French press and re-
spective homogenates were separated by centrifugation into pellet and surnatant
fractions. Results of these tests were examined by SDS-PAGE, showing that the
expression of the protein was easily obtained at all different induction times and
different temperatures (gels not shown). The expression of the target protein
increased during the time after IPTG induction, resulting in huge amount. How-
ever, at all tested condition (even at 18◦C), the enzyme was produced in form
of insoluble inclusion bodies, which were detected in the E. coli cell debris (lines
p). To confirm the identity of the target protein, an immunoblotting assay has
been performed using anti His-tagged antibody (Fig. 3.7).
The SDS-PAGE gel clearly points out a high basal expression of the target
protein, as noticeable in the lanes referring to non-induced cell. In fact pET
vectors, respect other E. coli based expression systems, suffer from genetic in-
stability [85]. In the system based on strain BL21(DE3), the coding sequence for
T7 RNA polymerase is located in the bacterial chromosome under the control of
the inducible LacUV5 -promoter while the coding sequence for the target protein
is cloned in a pET vector under control of T7-lac promoter. In the absence of
the inducer, typically isopropyl-β-D-thiogalactoside (IPTG), no (or a very small
quantity of) target protein should be present. Upon addition of IPTG, the T7
RNA polymerase is expressed and transcribes the DNA downstream from the
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Figure 3.7: 12% SDS-PAGE analysis (A) and Western blot (B) of Os-BVMO protein
expressed at 18◦C. PB: protein standard marker; NI: noninduced sample; 2h: 2 hours
induced sample; p: pellet fraction of induced sample; sur: soluble fraction of induced
sample.
T7-lac promoter. This enzyme is so effective that a basal expression level of the
desired protein can be present even in the absence of IPTG. The level of basal
expression can be partially reduced using an E. coli strain carrying the pLysS
plasmid and encoding for the T7 lysozyme an inhibitor of the T7 RNA poly-
merase [102]. Some attempts were made using BL21 (DE3) pLysS strain but
without significant results. Many classical strategies are available to improve
the solubility of an expressed protein. Decreasing the rate of protein synthesis
by lowering the temperature cultivation was already considered. However, low
temperature also reduces the activity of bacterial chaperonins. In order to over-
come this drawback an engineered strain was used, i.e. the E. coli ArcticExpress
strain. These cells co-express the cold-adapted chaperonins Cpn10 and Cpn60
from the psychrophilic bacterium Oleispira Antarctica, improving protein folding
process at lower temperatures. E. coli ArcticExpress cultures transformed with
Os-BVMO gene were grown at two different temperature, 18 and 4◦C, using 0.2
mM of IPTG concentration (Fig. 3.8).
As displayed from gels shown in the figure (Fig. 3.8), neither expression
in the specific host strain ArcticExpress was helpful to solve the problem since
the protein remained insoluble. Changing growth medium can be useful too
for protein solubility. Terrific Broth (TB) is a nutritionally rich medium [104]
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Figure 3.8: 12% SDS-PAGE analysis of cell extracts from E. coli ArcticExpress cells
transformed with Os-BVMO and grown at 18 and 4◦C, induced with IPTG 0.2mM.
PB: protein standard marker (kDa); NI: noninduced sample; 1h: 1 hours induced
sample; 3h: 3 hours induced sample p: pellet fraction of induced sample; sur: soluble
fraction of induced sample.
commonly used for cultures in the laboratory scale. Its formulation contains in-
creased concentrations of peptone, yeast extract, and glycerol as a carbon source
providing more essential element for protein folding and stability. A culture of
cells transformed with plasmid pOs-BVMO grown in TB medium was prepared
and after cell disruption no soluble protein was obtained (data not showed). A
final attempt in modifying growth conditions was performed adding riboflavin,
the natural precursor of FAD to the medium. Also this attempt was unsuccessful.
Recombinant expression in the form of fusion product is another possibility to im-
prove the solubility of a heterologous protein. Fusion partners are characterized
by their ability to enhance protein expression, reduce proteolytic degradation of
the recombinant protein, and improve both protein folding and solubility. One
of such fusion partners is SUMO (small ubiquitin-related modifier), a protein
consisting of about 100 residues; it modulates protein structure and function by
covalent modification of target proteins in eukaryotes [51, 72, 105]. Recently, a
system fit for performing an efficient expression of recombinant proteins fused to
SUMO in E. coli has been described [68]. One important feature of the SUMO-
system is that the expressed fusion protein can be cleaved by the highly specific
SUMO-protease, capable of generating a recombinant protein of interest with
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native N-terminal amino acids. We decided to clone the SUMO gene at 5’ of the
monooxygenase gene for obtaining the expression of a protein having SUMO at
its N-terminus. The starting material for the cloning was the genomic DNA of
the yeast Saccharomyces cerevisiae, containing a single SUMO gene (SMT3). A
first PCR reaction was performed using two specific primers (Smt3 est forward
and Smt3 est reverse), giving a PCR product 554 pb long. The obtained DNA
fragment was used as template for a second mutagenic PCR reaction, introduc-
ing the NcoI restriction site at both the extremities of the gene sequence (Fig.
3.9). Afterwards, a restriction digestion using NcoI was performed to prepare the
SUMO insert (308 pb) for the ligation into the pre-digested pET28a-Os-BVMO,
cut by the same restriction enzyme.
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Figure 3.9: 1% agarose gel analysis of the amplimer containing the stm3 gene from
Saccharomices cerevisiae, obtained by two-step amplification. M: standard marker
(Promega).
The resulting ligation product was used to transform chemically competent
XL1-Blue cells. Clones were analysed by restriction digestion and the correct ones
were transformed into the suitable BL21(DE3) cells; pre-cultures were grown
overnight and, on the following day, used to inoculate a main culture for ex-
pression. Also in the form of fusions, the proteins were very well expressed.
Unfortunately, however, their solubility was not improved and they remained in
the cell derbies after disruption.
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3.3 Pp-BVMO: Putative type I BVMO from
Physcomitrella patens
The moss Physcomitrella patens (Fig. 3.10) belongs to the family of Funariaceae
in the order Funariales within the class Broypsida [60] (Fig. 3.11). It grows in
late summer to autumn in temperate zones in an open distributed environment,
often close to the waterline [60]. This species has received increasing attention
in the recent years as a model organism, in particular for the study of plant
evolution. Indeed, it stands in an important phylogenetic position for illumi-
nating the evolutionary transition from the aquatic environment of algae to the
terrestrial one of higher plants. Moreover, it is the only plant that undergoes ho-
mologous recombination with a frequency that allows easy targeting of genes for
replacement and elimination. This, in turn, allows handy studying of gene func-
tion and helps in predicting the physiological role of genes in higher organisms.
Physcomitrella can be easily cultivated in laboratory conditions both in liquid
and solid media containing only inorganic salts. Cultivation on agar plates with
rich medium (PpNH4) was used only to obtain a starting culture for genomic
DNA extraction. Dr. Tomas Morosinotto (Department of Biology, University of
Padova) kindly provided the starting culture.
Figure 3.10: The moss Phiscomitrella patens (image from Laboratoire de Ge´ne´tique
et Biophysique des Plantes (LGBP), www.lgbp.univ-mrs.fr).
3.3.1 Cloning of Pp-BVMO
The genomic DNA extracted from a culture of Physcomitrella was used as original
template to obtain the putative Pp-BVMO gene sequence. A first PCR reaction,
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Kingdom: Plantae 
Division: Bryophyta 
Class: Bryopsida 
Order: Funariales 
Family: Funariaceae 
Genus: Physcomitrella 
Species: P. patens !
Figure 3.11: Taxonomic classification of Phiscomitrella patens.
using Pp3 forward and Pp4 reverse primers, was performed to obtain a 2188 pb
DNA fragment, which was employed as template for the second mutagenic PCR
reaction, using Pp1 forward and Pp2 reverse primers. The desired amplimer was
obtained: it was 1625 bp long and exactly contained the ORF bounded by the
chosen restriction sites (Fig. 3.12).
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Figure 3.12: 1% agarose gel analysis of of the preliminary 2188 bp and final 1625 bp
long PCR products (PCR1 and PCR2). M: standard marker (Promega).
Afterwards, a restriction digestion using both NcoI/NotI was performed to
prepare the insert for the ligation into pET28a. The resulting ligation product
was used to transform chemically competent XL1-Blue cells. Clones were anal-
ysed by PCR colony and analytical restriction digestion with NcoI/NotI. The
Pp3 primer, internal to the target sequence, and the universal T7 were used in
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the PCR colony screening getting a DNA fragment 1140 pb long (Fig. 3.13).
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Figure 3.13: (A) 1% agarose gel analysis of bands produced by colony PCR. (B)
1% agarose gel analysis of a positive plasmids pET28a-Pp-BVMO (from clone 11 and
clone 19) by restriction digestion using NcoI/NotI. M: standard marker (Promega).
3.3.2 Expression of Pp-BVMO
After transformation into BL21(DE3) strain, pre-cultures were grown overnight
and on the following day used to inoculate cultures for expression. Overexpres-
sion tests were performed in order to define the better conditions for expression.
Different growth temperatures were checked, 18, 30 and 37◦C (gel not shown).
An SDS-PAGE analysis was used to verify the expression of the protein at dif-
ferent induction time at the three temperatures and its solubility behavior after
cell disruption. We observed that the expression of the target protein increased
after the induction during the time at 18◦C and that the enzyme was partially
produced in soluble form, being detected in the protein soluble fraction too.
To confirm the identity of the target protein and its partial solubility, an im-
munoblotting assay was performed using an anti His-tag antibody (Fig. 3.14).
A first purification attempt by IMAC cromatography was performed without
any success; the obtained eluted solution contained completely uncolored and
aggregated protein. Because of the production of a likely mis-folded protein we
decide to utilize the ArcticExpress strain, trying to improve the folding process
As explained in paragraph 3.2.2 for the expression of the putative Os-BVMO,
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transformed ArcticExpress cells were grown at two different temperature, 18 and
4◦C and induced by different concentrations of IPTG (0.2, 0.02 and 0 mM) (Fig.
3.15). In fact, lowering temperature and inducer concentration can be helpful
in reducing the speed of protein synthesis, favoring not only a correct folding
process but also an improved solubility
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Figure 3.14: 12% SDS-PAGE analysis (A) and Western blot (B) of total extracts
of bacterial cells expressing Pp-BVMO at 18◦C. PB: protein standard marker; NI:
noninduced sample; 1h: 1 hour induced sample; 3h: 3 hours induced sample; 5h: 5
hours induced sample; 20h: 20 hours induced sample; p: pellet fraction of induced
sample; sur: soluble fraction of induced sample; Os: induced sample of Os (control
sample).
As displayed from both gels (Fig. 3.15) the expressed protein partially aggre-
gates in inclusion bodies, as shown by its presence in the pellet fractions, but is
also present in soluble fraction samples. Thus, a second purification attempt was
performed but during elution, non-colored fractions showing protein aggregation
were collected.
After this second unsuccessful attempt we concluded that something differ-
ent could be responsible for the incorrect folding of the recombinant protein.
Considering how highly and rapidly the target protein was expressed (even in
the absence of IPTG, Fig. 3.15), an insufficient amount of its flavin cofactor
might be a possible cause. So, as we did for the putative Os-BVMO, we changed
the composition of the growth medium by adding the natural precursor of FAD,
riboflavin. In this case, the adjustment was successful, leading to a higher propor-
tion of correctly folded, soluble versus unsoluble protein. Results of purification
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Figure 3.15: 12% SDS-PAGE analysis of cell extracts from E.coli ArcticExpress cells
transformed with Pp-BVMO, grown at 18 and 4◦C and induced at different IPTG
concentrations (0, 0.2 and 0.02 mM). PB: protein standard marker; NI: noninduced
sample; 20h: 20 hours induced sample; p: pellet fraction of induced sample; sur:
soluble fraction of induced sample.
of soluble Pp-BVMO are reported in the next paragraph.
3.3.3 Purification of Pp-BVMO
Since the expressed recombinant protein displays a C-terminal His6-tag, immo-
bilized metal affinity chromatography (IMAC) followed by desalting was chosen
as purification method. The purification was started from the soluble crude
extract, obtained by centrifugation after cell disruption by French Press. All
buffers used were pre-cooled at 4◦C and the fractions (crude extract or purified
enzyme) were kept in ice, since the stability of the recombinant enzyme at room
temperature was not known. Purification was performed by Ni-NTA chromatog-
raphy on a 5 ml column using a high concentration of imidazole, as elution agent.
During elution, positive fractions were identified by the bright yellow coloration
(Fig. 3.16), indicating that the flavin cofactor (FAD) was bound to the enzyme
[37]. The SDS-PAGE gel confirmed the identity and the presence of the putative
Pp-BVMO in different fractions, before and after purification. Only elution frac-
tions E2 and E3 were yellow colored, indicating the presence of correctly folded
recombinant Pp-BVMO (Fig. 3.17). The purified solution was then desalted
and finally concentrated by centrifuge filters. The evaluated concentration of the
65
3.4. Cm-BVMO: Putative type I BVMO from Cyanidioschizon merolae
purified protein was 158 mM.
Figure 3.16: Purification steps of Pp-BVMO via immobilized metal affinity chro-
matography (IMAC).
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Figure 3.17: 12% SDS-PAGE analysis of samples from expression and IMAC purifi-
cation of Pp-BVMO. M: protein standard marker; NI: noninduced sample; ON: over
night induced sample; p: pellet fraction of induced sample; sur: soluble fraction of
induced sample; Ft: flowthrough; E1,E2, E3: eluition fractions.
3.4 Cm-BVMO: Putative type I BVMO from
Cyanidioschizon merolae
Cyanidioschyzon merolae 10D is a primitive unicellular red alga (Fig. 3.18)
from the phylum Rhodophyta (Fig. 3.19), which lives in acidic environments
(like hot springs), even at a pH < 2 and temperature of 45◦C. It’s one of the
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photosynthetic eukaryotes with very simple cell architecture offering advantages
for studies on mitochondrion and chloroplast [59, 80]. The cell does not have a
rigid cell wall and contains a single nucleus, a single mitochondrion and a single
chloroplast, divisions of which can be highly synchronized by light/dark cycles
[107]. Its genome is really small, like 16 Mbp, (which is about 1/7 of that of
Arabidopsis thaliana and about 1/27 of that of rice Oryza sativa).
Figure 3.18: The unicellular red alga C. merolae 10D. The dividing cell contains a
nucleus, a V-shaped mitochondrion, a dumb-bell-shaped plastid, a microbody and a
Golgi apparatus, divisions of which can be highly synchronized by light/dark cycles
(images from NIES-1332 (http://mcc.nies.go.jp/) and from Matsuzaki et al. 2004 [7]).
Domain: Eukaryota 
Phylum: Rhodophyta 
Subphylum: Cyanidophytina 
Class: Cyanidiophyceae 
Order: Cyanidiales 
Family: Cyanidiaceae 
Genus Cyanidioschizon !
Figure 3.19: Taxonomic classification of Cyanidioschizon merolae10D.
The genome sequence of C. merolae 10D was published in 2004 [7], and all
sequence data can be downloaded from the Cyanidioschyzon merolae Genome
Project Web site (http://merolae.biol.s.u-tokyo.ac.jp/), whereas sequencing of
the chloroplast genome was accomplished in 1999 [81] and has revealed that the
chloroplast genome of this organism retains many genes that are not present in
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the chloroplast genomes of other algae and plants; they probably represent one
of the most ancestral plastid genomes. So, from an evolutionary perspective, C.
merolae, can be considered a model system for studying the origin, evolution and
fundamental mechanisms of eukaryotic cells. The strain NIES-1804, which we
purchased from the Microbial Culture Collection-Nies, (Japan), was identified by
Mio Ohnuma at Sardinia Island, Italy. The alga was cultivated in M-Allen liquid
medium and the starting culture was directly used for extraction of genomic
DNA. M-Allen is a medium for freshwater, terrestrial, hot spring and salt-water
algae; it contains organic salts, EDTA, metal traces with a pH of 2.5, using
sulfuric acid.
3.4.1 Cloning of Cm-BVMO
The genomic DNA extracted from the organism was used as starting material
to obtain the coding sequence of the putative Cm-BVMO. A first PCR reaction,
using Cm3 forward and Cm4 reverse primers, was performed to obtain a 2198 pb
DNA fragment, which was employed as template for the second mutagenic PCR
reaction, using Cm1 forward and Cm2 reverse primers. The final amplimer had
the attended size of 1627 bp (Fig. 3.20).
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Figure 3.20: 1% agarose gel analysis of preliminary 2198 bp and final 1627 bp PCR
products (PCR1 and PCR2). M: standard marker (Promega).
A restriction digestion using both enzymes NcoI and NotI was performed to
prepare the insert for the ligation into pET28a. The resulting ligation product
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was used to transform chemically competent XL1-Blue cells. Recombinant plas-
mids were examined by analytical restriction digestion with EcoRV. This analysis
led to the formation of three bands, whose size was compatible with the lengths
of 4326 bp, 2429 bp and 105 pb, as calculated for the digestion of the attended
plasmid pET28a-Cm-BVMO (Fig. 3.21). The smaller band is not visible on the
agarose gel, due to its low fluorescence (Fig. 3.22). One of the positive plasmids
was then analysed by NcoI/NotI restriction to confirm the presence of the 1627
bp DNA fragment.
Figure 3.21: Map of the plasmid pET28a-Cm-BVMO.
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Figure 3.22: 1% agarose gel analysis of NcoI/NotI (A) and EcoRV (B) restriction
pattern of plasmid pET28a-Cm-BVMO ; M: standard marker (Promega).
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3.4.2 Expression of Cm-BVMO
After transformation of chemically competent BL21 (DE3) cells by plasmid
pET28a-Cm-BVMO, a pre-culture was grown overnight and used the day af-
ter to inoculate a main culture for expression. Basing on the previous expression
tests for Os-BVMO and Pp-BVMO proteins, we decided to use 18◦C as growth
temperature for the culture. Moreover, in order to avoid a possible flavin cofac-
tor deficiency and a consequent protein misfolding, 100 µM riboflavin was added
to the culture medium. As shown by the SDS-PAGE of Fig. 3.23, the target
protein Cm-BVMO is well expressed after overnight induction by IPTG 0.2 mM.
As in the case of the recombinant protein from Physcomitrella, it was partially
produced in form of insoluble inclusion bodies and detected in the pellet fraction,
but a considerable quantity was also present in the soluble fraction.
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Figure 3.23: 12 % SDS-PAGE analysis of total extracts of cells transformed by plas-
mid pET28a-Cm-BVMO and induced at 18◦C: the recombinant Pp-BVMO. protein
is indicated by the arrow. PM: protein standard marker; NI: noninduced sample; I:
over night induced sample; p: pellet fraction of induced sample; sur: soluble fraction
of induced sample.
3.4.3 Purification of Cm-BVMO
Recombinant Cm-BVMO, supplied of His-tag, was purified by Ni2+-chelating
affinity chromatography starting from a soluble crude extract, obtained by cen-
trifugation after cell disruption by French Press. The resulting yellow protein
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fractions e1, e2, e3 and e4 were eluted and collected (Fig. 3.24). The presence of
the target protein during in these fractions as well as in other fractions collected
throughout the purification was examined by SDS-PAGE gel (Fig. 3.25). All
buffers used for the purification were pre-cooled at 4◦C and all fractions were
kept in ice. Then, fractions containing the purified enzyme were desalted and
finally concentrated by centrifuge filters. The evaluated concentration of the
purified protein was 356 mM.
Figure 3.24: Purification steps of Cm-BVMO via immobilized metal affinity chro-
matography (IMAC).
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Figure 3.25: 12% SDS-PAGE analysis of fraction from IMAC purification of Cm-
BVMO. Ft1, Ft2: flowthroughs; e1,e2,e3,e4: elution fractions.
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3.5 Te-BVMO: Putative type I BVMO from
Trichodesmium erythraeum
Trichodesmium erythraeum IMS101 is a marine filamentous cyanobacteria (Fig.
3.27) living in tropical and subtropical oceans. It is commonly called ”sea saw-
dust” because its colonies and large brown blooms can be mistaken as sandbars
by ships in the ocean (Fig. 3.26). It contain many gas vesicles aligned so that
their longitudinal axis is oriented perpendicular to the direction of the filament [7]
allowing its flotation according to changes in the concentration of carbohydrates
within the cell [19]. Photosynthetic lamallae can be seen throughout the cell,
but tend to be more populous toward the center of the cell [7]. Trichodesmium
erythraeum plays an important role in the nitrogen fixation using photosynthesis
[56]. It converts inorganic nitrogen gas to organic nitrogen that can be utilized
by other organisms. The complete genome of Trichodesmium erythraeum has
been sequenced by the DOE Joint Genome Institute (University of California)
and has been deposited in 2006.
Figure 3.26: Trichodesmium erythraeum IMS101(image from the Alfred Wegener
Institute (AWI) http://www.awi.de).
3.5.1 Cloning of Te-BVMO
The starting material for the cloning was genomic DNA provided by the lab of
prof. Ilana Berman-Frank, Faculty of Life Sciences of the Bar Ilan University,
Israel. Te5 forward and Te6 reverse primers were used in a first PCR reaction to
replicate a preliminary large DNA fragment of 1934 pb containing the gene coding
for the putative monooxygenase (Fig. 3.28, part A). Starting from the A(1)TG of
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Order: Oscillatoriales 
Genus: Trichodesmium; -
Figure 3.27: Taxonomic classification of Trichodesmium erythraeum IMS101.
the open reading frame a NcoI restriction site is present at position 651. In order
to remove this internal NcoI restriction site (which would have made following
cloning difficult) we choose to suppress it by performing amplification in two
steps. In the first step, two separate mutagenic PCR reactions were carried out
using the same template, that is the purified Te5-Te6 amplimer: primers Te1
forward was combined with Te9 reverse primer in the first PCR tube; primers
Te8 forward and Te2 reverse were mixed together in the second tube (Fig. 3.28,
part B). As previously described for the cloning of genes from other organisms,
the most external primers (Te1 and Te2) were designed to introduce NcoI and
NotI restriction sites respectively at the ATG and downstream of the stop codon.
Te8 and Te9 were complementary oligonucleotides differing from the wild-type
sequence by a single mis-match, able to suppress the undesired NcoI site without
altering the corresponding translated amino acid. From these mutagenic PCR
reactions we obtained two DNA fragments, 653 pb and 847 pb long, containing
complementary overhangs. Both were employed as DNA templates to perform
a last PCR amplification using Te1 forward and Te2 reverse as primers and
amplifying the desired 1487 pb long coding sequence (Fig. 3.28, part C).
Afterwards, the obtained ligation products were used to transform chemically
competent XL1-Blue cells. Recombinant clones were picked up and the corre-
sponding plasmid DNAs were isolated. Those containing the correct insert were
identified by restriction enzyme analysis using NcoI and NotI (Fig. 3.29). As
shown by the agarose gels displayed in Fig. 3.29, three positives colonies (Te2,
Te4, Te6) were identified in the screening, by the releasing of an insert of the
correct size (1487 pb). The plasmid purified from clone Te2 was sequenced and
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Figure 3.28: 1% agarose gel analysis of PCR amplification of the sequence coding
for the putative Te-BVMO. M: standard marker.
an aliquot of the corresponding culture was stocked in glycerol.
!"""""""""""""#$%"""""""""""#$&""""""""""#$'"
Figure 3.29: 1% agarose gel analysis of restriction by NcoI/NotI of recombinant
plasmids from clones obtained from bacterial transformation. M: standard marker.
3.5.2 Expression of Te-BVMO
As done for all other putative BVMO proteins, after transformation of the ap-
propriate BL21(DE3) strain, pre-cultures were grown overnight and used to in-
oculate cultures for expression. Overexpression tests were performed in order to
define the better conditions for expression. Different growth temperatures, 18,
30 and 37◦C, and different induction times were checked. SDS-PAGE analysis
was used to verify the expression and the solubility behavior of the protein after
cell disruption. We observed that, apparently, there was no expression of the
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target protein at all conditions tested (Fig. 3.30). An immunoblotting assay,
performed using anti-His tag antibody, confirmed the result of the expression
tests on two different clones, Te2 and Te4 (Fig. 3.31). The anti-His tag antibody
detected some bands at low apparent molecular weight: these were possibly due
to proteolytic cut/degradation of the recombinant protein or aspecific recogni-
tion of endogenous bacterial proteins, since similar bands had been detected by
the same antibody in analysis of recombinant putative BVMOs from Oryza and
Haloterrigena (see next paragraph). Differently from those cases, however, no
trace of the fully translated product was revealed.
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Figure 3.30: 12% SDS-PAGE analysis of total extracts from cells expressing Te-
BVMO, grown at 18, 30 and 37◦C and induced with IPTG 0.2 mM. M: protein standard
marker; NI: noninduced sample; 1h: 1 hour induced sample; 3h: 3 hours induced
sample; 5h: 5 hours induced sample; 20h: 20 hours induced sample; 24h: 24 hours
induced sample; p: pellet fraction of induced sample; sur: soluble fraction of induced
sample.
Re-sequencing of inserts and corresponding flanking regions on plasmids pET28a-
Te-BVMO Te2 and Te4 (i.e. promoter and terminator sequences) ruled out the
hypothesis that incidental mutation(s) could be responsible for switching off the
expression. We then considered the possibility that secondary structures of the
Te-BVMO transcript could block the beginning of the translation, preventing
recognition of the ribosome-binding site (RBS) or the initial codon AUG, or
could hamper elongation of the growing polypeptide (Fig. 3.32). As a matter of
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Figure 3.31: Ponceau Red stained PVDF membrane (A) and Western Blot (B) of
cell extracts from clones Te2 and Te4. M: protein standard marker; NI: noninduced
sample; 2h: 2 hour induced sample; p: pellet fraction of induced sample; sur: soluble
fraction of induced sample.
fact, the bioinformatics analysis of the Te-BVMO mRNA predicted possible sec-
ondary structures, one example of which is shown in Fig. 3.32. In this particular
secondary structure, i.e the one corresponding to the minimal free energy, we
observed the presence of a hairpin at the 5’-terminus of the mRNA. We wonder
if this hairpin could interfere with translation.
Figure 3.32: mRNA secondary structure of Te-BVMO
To investigate this possible hypothesis, we decided to engineer the transcript
by changing the 5’-terminal part of the Te-BVMO gene with the 5’-terminal part
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of the Pp-BVMO gene, very well-expressed in our system. In order to realize the
chimeric construct two mutagenic PCR reactions were carried out. The first one
was performed using Pp1 forward e PpTe1 reverse primers starting from the 2188
bp long ORF of P. patens as template DNA and obtaining the 5’-terminal part
of the chimeric gene. The second mutagenic PCR reaction was carried out using
PpTe2 forward e Te2 reverse primers and the 1934 bp long ORF of T. erythraeum
as template, in order to obtain the 3’-terminus of the designed construct. PpTe1
and PpTe2 primers present a complementary portion of 20 pb respectively to
P. patens and T. erythraeum and complementary 13 bp long tales for blending
the two obtained fragments; Pp1 and Te2 respectively introduce the restriction
sites NcoI and NotI at its two extremities. By a further final PCR reaction,
using Pp1 forwards and Te2 revers primers, the hybrid gene (1456 bp long) was
amplified (Fig. 3.33).
Figure 3.33: Cloning strategy used for production of the chimeric (Pp-Te-)gene.
Once digested by restriction enzymes, the hybrid ORF was used in a ligation
with pET, the products of which were transformed in chemically competent XL1-
Blue cells. Recombinant clones were picked up and the corresponding plasmid
DNAs were isolated: those containing the new chimeric insert were identified by
restriction enzyme analysis using NcoI/NotI. Hybrid plasmid Te2 was sequenced
and the corresponding colony was conserved in glycerol stock. BL21 (DE3)
cells were transformed by the new plasmid Te2 and overexpression tests were
performed. Two different growth temperatures were checked, 18 and 37◦C. In
both cases the result was the same of the preceding experiment: no expression of
the chimerical protein could be observed (data not shown). This result brought
us to conclude that the secondary structure of the mRNA at its 5’-terminus
could not be the only reason for suppression of Te-BVMO expression. Other
investigations are needed to solve the question.
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3.6 Ht-BVMO: Putative type I-BVMO from Haloter-
rigena turkmenica
Haloterrigena turkmenica DSM 5511 is the type strain of the species Haloter-
rigena turkmenica, which is the type species of the genus Haloterrigena (Fig.
3.35). It is an extreme halophilic archeum isolated from a sulphate saline soil
in Turkmenistan. On the basis of 16S rRNA analysis, it belongs to the Eur-
yarchaeota phylum that, in addition to extreme halophiles, includes strict anaer-
obic methanogens (procaryotes that produce methane), differing on their physiol-
ogy. Haloterrigena turkmenica is a relatively fast growing, chemoorganotrophic,
carotenoid containing organism, requiring at least 2 M NaCl for growth. Its cells
occur mostly as single cells (Fig. 3.34); colonies are pigmented red or light pink
due of the presence of C50-carotenoids. It’s a chemo-organotrophic and aerobic
organism [111].
Figure 3.34: Scanning electron micrograph of H. turkmenica DSM 5511 (image from
Saunders et al. 2010 [93].
3.6.1 Cloning of Ht-BVMO
The gene coding for the putative Ht-BVMO (locus tag=Htur 3838) has been
identified on plasmid pHTUR01 of H. turkmenica DSM 5511. On the base of
observed sequence similarity, the gene product is annotated in data-banks as
“cyclohexanone monooxygenase”. The organism Haloterrigena turkmenica is
available at the German Collection of Microorganisms and Cell Cultures (DSMZ)
but the presence of the plasmid is not assured. For this reason, a synthetic gene
encoding the putative CHMO was purchased from GeneArt R©, cloned into the
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Domain: Archaea 
Kingdom: Euryarchaeota 
Phylum: Euryarchaeota 
Class: Halobacteria 
Order: Halobacteriales 
Family: Halobacteriaceae 
Genus: Haloterrigena !
Figure 3.35: Taxonomic classification of Haloterrigena turkmenica DSM 5511.
plasmid pMK-RQ (kanR) (Fig. 3.36). The gene was drawn and synthesized with
the flanking restriction sites NcoI and NotI, required for cloning, and a codon
usage optimized for translation in E. coli.
Figure 3.36: Map of the plasmid pHtur-CHMO-pMK-RQ.
The existing NcoI/NotI restriction sites in the pHtur-CHMO pMK-RQ plas-
mid would have facilitate the cloning step if it had not been. Digestion of the
purchased plasmid by enzymes NcoI and NotI produced three DNA fragments
1653, 1240 and 1068 pb long, because of the presence of another NcoI restriction
site in the carrier vector pMK-RQ (Fig. 3.37). We therefore choose a “shot-gun”
cloning approach in which all DNA fragments produced by NcoI/NotI restric-
tion digestion were mixed in the same ligation reaction with pre-digested pET28a.
Being possible different ligation products, a special attention was given to the
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screening of recombinant colonies.
!"
#$$$"%&"
#'$$"%&"
Figure 3.37: 1% agarose gel analysis of NcoI/NotI digestion pattern of pHtur-
CHMO pMK-RQ; M: standard marker (Promega).
Transformed XL1-Blue clones were picked up and the corresponding plas-
mid DNA was isolated: those containing the correct insert were identified by
restriction enzyme analysis using NcoI/NotI. As shown by the agarose gels, two
positives colonies (Ht5 and Ht35) were identified by the presence of released in-
serts of the correct size (1653 pb), corresponding to the open reading frame for
Ht-BVMO. One of the two selected plasmids was sequenced and the correspond-
ing colony was conserved in glycerol stock (Fig. 3.38).
3.6.2 Expression of Ht-BVMO
After transformation of the BL21(DE3) expression strain by plasmid pHt5, pre-
cultures were grown overnight and used to inoculate cultures for expression the
following day. Tests were performed in order to define the better conditions
for expression. Different growth temperatures were checked, 18, 30 and 37◦C.
SDS-PAGE analysis was used to verify the expression of the protein at different
induction time at the three temperatures and its solubility behavior after cell
disruption. We observed that from the third hour after IPTG induction a large
amount of protein was produced at both temperatures tested, even at the lowest
one of 18◦C. First of all, we noticed that the apparent molecular weight of the
expressed protein (80 kDa) was very different from the theoretical one (62 kDa).
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Figure 3.38: 1% agarose gel analysis of the digestion of the obtained plasmids using
NcoI/NotI. M: standard marker.
Furthermore, the overexpressed protein was possibly insoluble and collected in
inclusion bodies, being detected in the pellet fraction (Fig. 3.39). The identity of
the target protein was confirmed by an immunoblotting assay, performed using
anti-His tagged antibody (Fig. 3.40).
A possible explication for the unusual electrophoretic migration of the recom-
binant protein was the presence of a post-translational covalent modification of
the target protein, since all samples for SDS-PAGE analysis had been prepared
in a denaturing loading buffer and subjected to boiling. However, it is known
from the literature that proteins containing high quantity of negatively charged
amino acids can have an abnormal migration in SDS-PAGE. Indeed, Ht-BVMO
contains 169 charged amino acids, 119 of which negatively charged. The ac-
tual reason for the apparent molecular weight of the protein, higher than the
calculated value, was not further investigated.
Concluding remarks:
Using bioinformatics tools we have identified and selected five new putative BV-
MOs from five different organisms, Oryza sativa (Os; land plant), Physcomitrella
patens (Pp; moss), Cyanidioschyzon merolae (Cm; red alga), Trichodesmium ery-
thraeum (Te; cyanobacterium), Haloterrigena turkmenica (Ht; archibacterium).
In particular, basing on most updated literature, the photosynthetic eukary-
otes Oryza, Physcomitrella and Cyanidioschyzon would result very uncommon
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Figure 3.39: 12% SDS-PAGE analysis of total extracts from E.coli cells expressing
Ht-BVMO, grown at 18, 30 and 37◦Cand induced by IPTG 0.2 mM. M: protein stan-
dard marker; NI: noninduced sample; 1h: 1 hour induced sample; 3h: 3 hours induced
sample; 5h: 5 hours induced sample; 15h: 15 hours induced sample; 24h: 24 hours
induced sample; p: pellet fraction of induced sample; sur: soluble fraction of induced
sample.
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Figure 3.40: Western Blot (A) and PVDF membrane stained by Ponceau Red (B) of
total extracts from E. coli cells expressing Ht-BVMO. M: protein standard marker; NI:
noninduced sample; 1h: 1 hour induced sample; p: pellet fraction of induced sample;
sur: soluble fraction of induced sample.
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sources for BVMOs. Although the starting material was different, the cloning
strategy used was the same for all the five putative enzymes. Overexpression of
enzymes was made in E. coli BL21 (DE3) and tested at 18, 30, and 37◦Cand
concentration of IPTG ranging from 0.2 to 1 mM. Whole cells and partially puri-
fied extracts were analysed by SDS-PAGE. All the putative enzymes, apart from
Te-BVMO, were very well expressed, but they were present in the cell debries
after cell homogenization. Thus, solubility resulted to be the main difficulty. To
overcome the problem of correct folding and confinement in inclusion bodies, we
tried many known strategies, like expression at low temperature in the E.coli
ArcticExpress strain containing cold-adapted chaperones or fusion to suitable
partners. Adding an excess of riboflavin, the precursor of the FAD, to the cul-
ture resulted in successful folding for the proteins from Physcomitrella patens
and Cyanidioschyzon merolae, showing the importance of the flavin cofactor in
the process. Overall result concerning cloning, expression and purification of the
five putative type I BVMOs is summarized in Fig. 3.41.
Figure 3.41: Cloning, expression and purification of the five putative type I BVMOs
identified.
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Abstract:
After cloning and expression of five putative genes encoding type I Baeyer-Villiger
monooxygenases, only two of them were successfully purified by IMAC chromatog-
raphy. One BVMO was from Phiscomitrella patens (Pp-BVMO) and the other one
from Cyanidioschizon merolae (Cm-BVMO). Because the BVMO-identifying ”finger-
print” motif in Pp-BVMO (FxGxxxYxxxWP) differs in one amino acid with respect
to the typical (FxGxxxHxxxWP) sequence motif of type I BVMOs, a mutant of the
flavoenzyme was prepared by site-directed mutagenesis, in order to repair the Tyr (Y)
residue by introducing a His (H). A biocatalytic characterization of the three gener-
ated enzymes, Cm-BVMO, Pp-BVMO and Pp-BVMO-Y173H was carried out at the
Molecular Enzymology group of the Groningen Biomolecular Science and Biotechnol-
ogy Institute (GBB), University of Groningen (The Netherlands) headed by Prof. Dr.
Marco Fraaije. After verification of their Baeyer-Villiger monooxygenase activity, con-
ditions optimization (pH, temperature and stability) has been performed. After that,
the enzymes were tested to investigate their substrate specificity. A steady-state kinetic
analysis was carried out in order to obtain the kinetics parameters and some conver-
sions were made in order to determine the selectivity profile of the newly discovered
BVMOs.
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4.1 Enzyme activity and concentration
The flavin cofactor present in flavoproteins is essential as adaptable redox cat-
alyst for oxidation-reduction reactions. The flavin cofactor is derived from the
riboflavin precursor (vitamin B2) which consists of two parts: an isoalloxazine
ring system, responsible for the yellow colour of the oxidized form, and a ribose
moiety. Flavin mononucleotide, FMN consists of a molecule of riboflavin linked
to a phosphate group on the 5’-hydroxyl group of the ribose chain. Phosphoryla-
tion of riboflavin is achieved by a riboflavin kinase. Flavin adenine dinucleotide
(FAD), the most common flavin cofactor, is formed from a molecule of FMN
and a molecule of adenosine triphosphate (ATP) joined together by action of
FAD synthetase. The result is a riboflavin-diphospho-adenosine molecule, with
the diphosphate group attached to the 5’-hydroxyl group of the linearized ri-
bose on one side and a hydroxyl group of the adosine cyclic ribose on the other
side (Fig. 4.1). Both riboflavin derivatives, flavin mononucleotide (FMN) and
flavin adenine dinucleotide (FAD), function as cofactors in a wide variety of re-
dox enzymes. In fact they can act as oxidizing agents because of the ability of
the isoalloxazine ring to accept a pair of hydrogen atoms yielding the reduced
forms of the flavoproteins (FMNH2 and FADH2) (Fig. 4.2). It is well known
that flavins are capable of accepting both one- and two-electrons and, as a re-
sult, they can exist in three oxidation states, the oxidized state, the one-electron
reduced semiquinone state (flavosemiquinone) and the two-electron reduced hy-
droquinone state (flavohydroquinone). Depending on the protonation state there
are many forms of the flavin for each oxidation state (Fig. 4.3).
An interesting aspect of flavins is that each of these redox states has spe-
cific spectral properties, making it relatively easy to follow redox transitions by
spectral changes. In fact, in the oxidized form the flavin exhibits two absorp-
tion peaks at ≈ 370 and ≈ 450 nm. The exact shape, position and intensity
of these absorbance peaks dependent upon the protein environment. Reduction
of the flavin to its two-electron reduced form results in the loss of the typical
two absorbance peaks in the UV-visible region. The purified BVMOs all ex-
hibited typical flavin absorption spectra indicating that they indeed contain a
flavin cofactor, presumably FAD. To verify their activity towards the coenzyme
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NADPH, an excess of reducing equivalents was added and UV-vis spectra were
detected before and after NADPH addition (Fig. 4.4). The typical flavin spec-
trum was nearly completely lost upon adding NADPH confirming that NADPH
is indeed an effective electron donor for these BVMOs. By knowing the extinc-
tion coefficient for free FAD (εFAD, 450 nm = 11,300 M
−1 cm−1) it is possible to
quantify the exact amount of the flavoprotein by calculating the concentration
of free FAD of the enzyme after denaturation. By this approach, the extinction
coefficient of the flavin-containing enzymes could be calculated by comparing the
absorption spectra before and after denaturing with 0.1% SDS. Assuming that
the absorption spectrum of the unfolded protein can be compared to that of free
FAD (εFAD, 450 nm = 11.3 mM
−1 cm−1), a molar extinction coefficient of 11.7,
13.7 and 11.9 mM−1 cm−1 (all at 450 nm), can be calculated for the native forms
of Cm, Pp and PpY173H, respectively.
Figure 4.1: Structure of riboflavin, FMN and FAD.
Figure 4.2: 2-Electron reduction of the isoalloxazine ring in flavin cofactors.
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Figure 4.3: Different redox and protonation states of FAD.
4.2 pH optimum and temperature stability
All enzymes have an optimal pH and temperature at which reaction rates go
fastest without denaturing the enzyme [18]. To determine the pH and tempera-
ture optima, the NADPH depletion assay was employed while varying the pH and
temperature. In the NADPH depletion assay, the consumption of NADPH by a
BVMO can be conveniently monitored by measuring the absorbance of NADPH
at 340 nm at which the reduced coenzyme absorbs light.
The type I BVMOs all showed a bell-shaped pH profile with maximum ac-
tivity for bicyclo[3.2.0]hept-2-en-6-one at pH 8.5 for Cm-BVMO and pH 8.0 for
Pp-BVMO and PpY173H-BVMO. An optimum pH around 8 has also been found
for PAMO, whereas for HAPMO and CHMO pH 7.5 and 9, respectively, were
found to be the pH for maximum activity (Fig. 4.5).
The temperature optima were measured between 17◦C and 70◦C. For Cm-
BVMO this revealed an increase of enzymatic activity with an increase of tem-
perature until 70◦C. At the latter temperature the initial enzymatic activity was
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Figure 4.4: Uv-vis spectra of Cm, Pp and PpY173H before and after addition of
NADPH. Spectra of native protein (solid line) and after addition of an excess of
NADPH (dashed line).
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five-fold higher when compared to the activity at 30◦C (Fig. 4.5). Incubation
of the enzyme for 1.5 h resulted in full retention of enzymatic activity between
20◦C and 42◦C. Higher incubation temperatures led to inactivation of the en-
zyme. Cm-BVMO seems to be a reasonably thermostable enzyme. Considering
that Cyanidioschizon merolae typically grows at 45◦C, this result was not so
unexpected. The only thermostable type I BVMO found so far was discovered
by Fraaije et al. [37] in Thermobifida fusca exhibiting an activity half-life of 24
h at 52◦C. The optimal temperature for Pp-BVMO and Pp-BVM-Y173H was
probed between 17◦C and 40◦C and it proofed to be around 25◦C and 30◦C for
Pp-BVMO and Pp-BVMO-Y173H, respectively. Concerning stability, after 1.5
h of incubation both enzymes retained their activity between 17◦C and 25◦C.
4.3 Determining unfolding temperature (Tm)
Protein stability can be also analysed as the tendency of a protein to unfold. One
of the methods to measure stability by determining the apparent unfolding or
melting temperature of a protein (Tm). Unfolding experiments on Cm-BVMO,
Pp-BVMO and Pp-BVMO-Y173H were performed using the ThermoFAD method,
a Thermofluor R©-adapted flavin ad hoc detection system for measuring the stabil-
ity of flavoproteins. Using the Thermofluor R© technique it is possible to measure
the unfolding temperature of a protein through evaluation of the fluorescence
of a dye in a Real-Time PCR instrument. As soon as the protein unfolds, the
fluorescent dye will report on this. In the ThermoFAD method the flavin co-
factor is used as an internal probe releasing fluorescence as soon as the protein
denatures [34]. Usually a temperature gradient is applied, from 20◦C to 90◦C,
detecting the fluorescence signal of the cofactor during heating. A sigmoidal
curve is obtained by plotting the fluorescence intensity against the temperature.
By determining the derivative of this sigmoidal curve, the melting temperature
(Tm), of the protein can be determined.
Unfolding experiments using the ThermoFAD method revealed that the Tm
of Pp-BVMO is 44◦C and is comparable with that of the mutant PpY173H-
BVMO (43.5◦C). Apparently, the introduction of the ”correct” histidine residue
in the “fingerprint” motif of the mutant does not affect the melting temperature
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Figure 4.5: Optimum pH and temperature values for Cm, Pp and PpY173H.
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of the enzyme. The Tm of Cm-BVMO was shown to be 56◦C, which is con-
siderably higher when compared with most known BVMOs and it confirms the
measured thermostability of the enzyme (Fig. 4.6).
Moreover, a pH screening was performed with Cm-BVMO in order to evaluate
changes in Tm at different pH values. In Tabble 4.1 the Tm values obtained for a
set of different pH values are reported. The results coincide with those obtained
from the optimum pH experiments. The best Tm value is at pH 8.5 which is
also the optimum pH found for the enzyme (Table 4.1).
Figure 4.6: Melting curve derivatives of Cm (dot line), Pp (solid line), PpY173H
(dashed line).
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Table 4.1: Melting temperatures obtained at different pH value.
4.4 Substrate profiling
To explore the biocatalytic potential of these new BVMOs a broad range of
potential substrates was used in a so-called phosphate assay. In this indirect
assay the Baeyer-Villiger oxidation is coupled with a regeneration reaction catal-
ysed by a phosphite dehydrogenase (PTDH). PTDH is able to generate one
molecule of phosphate, starting from a molecule of phosphite, for the regenera-
tion of one NADPH molecule. The formed phosphate can be quantified by using
a chromogenic reaction allowing spectrophotometric detection of the degree of
conversion.
A collection of 46 substrates, that have been found to be converted by BV-
MOs, were tested. They belong to different types of molecule classes, e.g. lin-
ear and cyclic aliphatic ketones, aryl and aromatic ketones, steroids, aromatic
amines, and aromatic sulfides. The substrate scope obtained for each enzyme is
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summarized in Tab 4.2.
In general all the three BVMOs seem to have a broad substrate scope. As
expected, they exhibit significant activity against bicycloheptenone, a typical
substrate for type I BVMOs, and used as substrate for the NADPH depletion
assays mentioned above. Good activity was also observed for linear ketones, in
particular long-chain alkanones. Phenylacetone and some derivatives also seem to
be good substrates, as well as some cyclic ketones like cyclopentanone and some
sulfides. By comparing Pp-BVMO and the corresponding mutant Pp-BVMO-
Y173H, the latter one seems to display a larger substrate profile suggesting a
role of the mutated residue for substrate acceptance. Some other potential sub-
strates such as acetone, indanone, phenindione, cyclopentadecanone, benzoin and
steroids were poor or not accepted as substrates. To validate the results obtained
from this preliminary substrate-screening assay, a set of selected substrates was
chosen for further kinetics analysis and to evaluate some conversions by GC and
GC-MS analysis.
4.5 Steady-state kinetics
Steady-state kinetic parameters of the three isolated enzymes, Cm-BVMO, Pp-
BVMO and Pp-BVMO-Y173H were determined in 50 mM Tris/HCl using the
optimal conditions for each enzyme, that are pH 8.0, at 25◦C for Pp-BVMO and
Pp-BVMO-H173Y and, pH 8.5, at 35◦C for Cm-BVMO. Bicyclo[3.2.0]hept-2-en-
6-one and NADPH were utilized as substrates. All the three enzymes showed
a typical Michaelis-Menten behaviour and the kinetics parameters k cat and K M
were calculated for a set of identified substrates in the preliminary screening as-
say. Selected substrates were linear aliphatic ketones, cyclic aliphatic ketones,
aromatic ketones, and some sulfides. In particular for the linear ketone con-
taining eight carbon atoms, the position of the keto group on the molecule was
investigated. In Table 4.3 and Table 4.4 the results are summarized obtained for
Cm, Pp and PpY173H, respectively.
In general, by comparing Michaelis constants for all the substrates and for all
the three enzymes, it is worth noting that the K M values are in the micromolar
range, which are very low values for non-natural substrates. More variation was
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 Substrate Cm Pp PpY173H 
1 Acetone +   
2 Methylketone + +  
3 Methyl vinyl ketone + + + 
4 2-Octanone ++ ++ +++ 
5 3-Octanone + ++ + 
6 4-Octanone +   
7 2-Dodecanone +++ ++ +++ 
8 Butyl levulinate +++ + +++ 
11 3-Methyl-2,4-pentanedione +  + 
12 Cyclobutanone  + + + 
13 Cyclopentanone  ++ + ++ 
14 Cyclohexanone  +  + 
15 Cyclopentadecanone    + 
16 2-Oxocyclohexanecarbonitrile   ++ +++ 
17 4-Methylcyclohexanone  + + + 
18 2-Propylcyclohexanone   + + 
21 Dihydrocarvone   + 
22 Cyclopropylmethylketone +  ++ 
23 Norcamphor  + +++ 
24 Bicycloheptenone ++ ++ + 
25 Progesterone   + 
26 Androstenedione   +++ 
27 4-Dimethylaminobenzaldehyde  + + 
28 Nicotin   ++ 
31 Thioanisole +   
32 Benzylethyl sulfide ++ +++  
33 Benzylphenyl sulfide   +++ 
34 Ethionamide  +  
35 Diphenylmethylthioacetamide   + 
36 Thiacetazone   + 
37 Indole +  +++ 
38 3-Acetylindole   ++ 
41 5-Mathylfurfural + ++ + 
42 Benzaldehyde  + + 
43 Acetophenone  + ++ 
44 4-Hydroxyacetophenone  + + 
45 2,6-Dihydroacetophenone   +++ 
46 3-Phenylpentane-2,4-dione ++ ++ +++ 
47 Phenylacetone +++ ++ +++ 
48 4-(4-Hydroxyphenyl)-2-butanone +++ +++ + 
51 2-Phenylcyclohexanone   + 
52 Benzoin    
53 Phenindione    
54 2-Indanone  + + 
55 1-Indanone  + + 
56 6-Hydroxy-1-indanone +   
Table 4.2: Substrate scope. Observed activities measured by phosphate formation
are shown for Cm-BVMO, Pp-BVMO and Pp-BVMO-Y173H. Activities are indicated
as +, ++ or +++ and reflect a 1.2-, 2- or 5-fold increase in phosphate formation, re-
spectively, when compared with uncoupling reactions, which lack the tested compound.
Substrate structure are listed in Chapter 6-Material and Methods.
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found for the k cat values suggesting different rates of catalysis depending on the
substrate considered. Unfortunately, also the k cat values are considerably low.
Cm exhibits the best catalytic efficiency against 2-dodecanone (k cat/K M 97.000
s−1 mM−1), which seems one of the best substrates found for this enzymes.
Octanone appears to be the second best substrate. In particular, if we look at the
K M and k cat/K M, the position of the keto group at C3 seems to be the preferred
one. By comparing all the positions of the carbonyl function in octanone it
can be noticed that the Michaelis constant is the main parameters influencing
the catalytic efficiency because the k cat values were found to be similar for all
the positions investigated. Also for Pp and PpY173H linear ketones seem to be
very well accepted substrates; 2-dodecanone is the one with the highest catalytic
efficiency. Different from the position of the keto group in octanone for Cm, Pp
prefers the keto group at position 2. 4-octanone is not well accepted by both Pp
enzymes and the data are in agreement also with the previous substrate-screening
assay (Table 4.1). As for Cm the k cat values, for all the four linear C8-ketones
tested, are approximately in the same range. Comparing turnover numbers of
Pp and PpY173H it can be concluded that the mutant appears to be faster.
Cm, Pp and PpY173H are able to oxidize some substituted aryl ketones like
phenylacetone and 4-(4-hydroxyphenyl)-2-butanone. The latter compound is a
well-accepted substrate, especially for Pp and PpY173H. Moreover the kinetic
analysis revealed a poor activity against butyl levulinate and 3-phenylpentane-
2,4-dione which is in contrast with the preliminary results of the substrate screen-
ing assay. Thioanisole is accepted only by PpY173H whereas benzyl ethyl sulfide
is converted by both Pp and PpY173H. The affinity for the coenzyme NADPH
was found to be very high, as a K M value < 5 µM was determined. Due to the
limited solubility, other substrates such as 4-dimethylaminobenzaldehyde and
3-acetylindole could not be investigated for kinetic analysis.
As previously mentioned the general observation from the kinetic analysis
is that the enzymes display rather low catalytic efficiencies, while micromolar
range K M values were found, no more than 0,4 s
−1 for k cat and around 103 s−1
M−1 for k cat/K M were found. Usually a k cat for an enzyme is > 1 s−1, (most
k cat values are in the range of 1-100 s
−1) and, the k cat/K M is ˜102 s−1 M−1 while
k cat/K M values are normally in the range of 10
3-106 M−1 s−1. It is known that
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!!!!!
 Cm 
Substrate KM  [mM] 
kcat  
[s-1] 
kcat/KM  
[s-1 mM] 
2-Dodecanone  0,004 ± 0,001 0,383 ± 0,018 97,664 
Octanal  0,010 ± 0,008 0,252 ± 0,043 25,325 
2-Octanone  0,011 ± 0,006 0,250 ± 0,031 23,271 
3-Octanone  0,003 ± 0,0005 0,210 ± 0,006 70,036 
4-Octanone  0,004 ± 0,0009 0,202 ± 0,006 44,141 
4-(4-
Hydroxyphenyl)-2- 
butanone  
0,007 ± 0,0007 0,079 ± 0,002 11,071 
Bicyclo[3.2.0]hept-
2-en-6-one  
0,004 ± 0,0007 0,085 ± 0,002 20,721 
Butyl levulinate 
 
0,205 ± 0,091 0,181 ± 0,030   0,884 
3-Phenylpentane-
2,4-dione 
 
0,099 ± 0,026 0,015 ± 0,001   0,153 
Phenylacetone 
 
0,097 ± 0,071 0,032 ± 0,006   0,330 
O
O
O
O
O
HO O
O
O
O
O
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O
Table 4.3: Steady-state kinetic analysis of Cm.
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Table 4.4: Steady-state kinetic analysis of Pp and PpY173H. 99
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natural selection shapes the regulation of metabolic enzymes and plays a role in
the evolution of enzymatic kinetic parameters, including the turnover number
(k cat) and the Michaelis constant (K M). Kinetic parameters of enzymes belong-
ing to the central metabolism typically are more efficient with respect to these
of the intermediate and secondary ones. Such variations suggest a strong selec-
tive pressure towards primary metabolism enzymes, which are forced to increase
their rates. However, for enzymes operating in secondary metabolism, which
work only under specific conditions or for short periods of time, the selective
pressure is weaker resulting in moderate/low k cat and k cat/K M values. Also for
this reason identification of their natural substrate and reaction for secondary
metabolism enzymes remains a demanding task. The photosynthetic eukaryotes
Cm, Pp and the mutant PpY173H seem to fit in this hypothesis. Their substrate
preferences point towards linear alkanones, structurally similar to side chains of
chlorophylls and pheophytins, and could suggest some involvement in modifica-
tions of photosynthetic pigments. Furthermore, low k cat/K M values in the range
of 103 M−1 s−1, or even lower, are commonly seen in plant secondary metabolism
enzymes [86, 40].
4.6 Conversions
Biotransformations using purified enzymes and different types of substrates were
investigated using GC and GC-MS analysis in order to detect both substrates
and products. PTDH and phosphite were added for cofactor regeneration.
Conversions of various bicyclic ketones have been studied with CHMO [91].
In particular, bicyclo[3.2.0]hept-2-en-6-one is used to probe the bocatalytic po-
tential of type I BVMOs. This conversion is a good example of regiodivergent
parallel kinetic resolution (PKR) because the racemic substrate (+)-(1R,5S)/(–)-
(1S,5R) leads to two regioisomeric compounds (–)-(1S,5R) and (–)-(1R,5S) (Fig.
4.6). In fact, incubation of this racemic bicyclic ketone, with Acinetobacter
strains yields the two regioisomeric lactones with almost total stereoselectivity;
one originates from a “normal” Baeyer-Villiger-type oxygen insertion between
the more substituted carbon atom and the carbonyl group, the second is formed
with the chemically disfavoured regiochemistry [2]. The chiral lactones pro-
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duced are relevant building blocks for the chemical synthesis of prostaglandins.
Thus, CHMO is able to produce equimolar amount of the “normal” (–)-(1S,5R)
and “abnormal” (–)-(1R,5S) lactones in nearly enantiomerically pure form (ee
95%). CPMO instead yields mainly “normal” lactones (–)-(1S,5R) and (+)-
(1R,5S) with low enantioselectivity. The conversion of this racemic substrate
by HAPMO generates (–)-(1S,5R) and (+)-(1S,5R) lactones in equal amounts
starting from (–)-(1R,5S) enantiomer, whereas it has shown more regioselective
against the other enantiomer (+)-(1S,5R). The final enantioselectivity is not high
enough, resulting in 77% ee for (–)-(1S,5R) and 34% ee for (–)-(1R,5S) lactones
[55].
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Figure 4.7: Possible structures of bicyclo[3.2.0]hept-2-en-6-one isomers and lactones
formed by type I BVMO activity.
The behaviour of Cm towards the same racemic substrate (Fig. 4.8) dis-
plays, as for HAPMO, a significant preference for (+)-(1R,5S) enantiomer. But
in contrast to CHMO, the regioselectivity is not achieved in a good percent-
age, 73% for the expected (–)-(1S,5R) and 27% for the unexpected (+)-(1S,5R),
and the same is for the other enantiomer getting 88% for (+)-(1R,5S) and 12%
for (–)-(1R,5S), finally obtaining the formation of all the four possible lactone
products in different amounts. “Normal” lactones for both, the fast and slow
reactions, are mainly produced. The ee values of the product mixture resulting
from complete conversion are 12% for the “normal” (+)-(1R,5S) and 37% for
the “abnormal” (+)-(1S,5R). After 5 hours the racemic substrate is fully con-
verted. Pp and PpY173H show approximately the same behaviour (Fig. 4.8).
The favoured substrate is the (+)-(1R,5S) enantiomer, mainly producing 76%
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and 72% of the expected (-)-(1S,5R) and 24% and 28% of the (+)-(1S,5R), re-
spectively. PpY173H exhibits much higher regioselectivity in the conversion of
the other (–)-(1S,5R) substrate yielding 95% for the normal lactone and 5% for
the abnormal one, whereas for Pp the percentages are 62% and 4% for the ex-
pected and unexpected lactones produced considering that the conversion of such
slow reaction after 16 hours is not complete but is 66% . Also in this case ee
values for the “normal” and “abnormal” enantiomeric products are too low to
be of practical significance (Table 4.5).
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Table 4.5: Regiodivergent biooxidation by Cm, Pp and PpY173H.
Conv (%) = conversion
Ratio between normal and abnormal lactone
Cm, Pp and PpY173H are able to oxidize other compounds like long chain
alkanones, phenylacetone and cyclic ketones (Table 4.6). Conversion of these
ketones resulted in the formation of the expected ester product, obeying the
stereochemical rule of Baeyer-Villiger reactions where the migrating group is the
most substituted. Pp and PpY173H give poor conversion of cyclopentanone and
almost no conversion of cyclohexanone. Cm is able to convert in a good amount
the latter compound but it cannot transform cyclopentanone to the correspond-
ing ε-caprolactone. In the case of 2-octanone, 3-octanone and 4-octanone, all of
them are fully converted by Cm to the expected esters. PpY173H performs full
conversion of 2-octanone and 3-octanone and poor transformation of 4-octanone
whereas Pp is able to oxidize in good amount only the first two linear ketones.
This result is found to be in line with the substrate profiling study (Table 4.1)
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Cm
Pp
PpY173H
Figure 4.8: Time course of Cm (A), Pp (B) and PpY173H (C) catalyzed
oxidation of racemic bicyclo[3.2.0]hept-2-en-6-one (–)-(1R,5S)/(+)-(1S,5R) to 2-
oxabicyclo[3.3.0]oct-6-en-3-one (–)-(1S,5R)/(+)-(1R,5S) and 3-oxabicyclo[3.3.0]oct-6-
en-2-one (+)-(1S,5R)/(–)-(1R,5S).
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and also with the steady-state kinetic analysis (Table 4.2 and Table 4.3). Also
octanal has found to be a well accepted substrate for these enzymes but we
were not able to detect neither substrate nor the corresponding product by GC
analysis. Finally phenylacetone is fully converted by all the three enzymes.
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Table 4.6: Conversion of some identified substrates and corresponding products.
4.7 UV-visible spectrum of Cm-BVMO
As described in paragraph 4.1, flavins and flavoproteins in their oxidized state
are typically yellow with an absorption spectrum in the UV and visble spec-
tra range characterized by two resolved bands at around 450 and 370 nm. In
104
Chapter 4. Characterization of Type I BVMOs from Photosynthetic Eukaryotes:
Cm-BVMO and Pp-BVMO
particular, flavoproteins exhibit a pronounced spectral variability in term of po-
sition of the absorbance maxima, as well as their extinction coefficients and peak
ratio, reflecting different environments of the flavin binding-site of the protein
[78]. On the other hand, the overall shape of their UV-visible spectra (oxidized
form) remains basically the same. By carefully observing the UV-vis spectrum
of native Cm-BVMO we noticed a significant variation in its general shape (Fig.
4.4), which shows a higher peak around 450 nm and a nearly complete lack
of minimum between both peaks resulting in a quite unusual and distinctive
UV-visible spectrum. As just mentioned, the protein moiety perturbs the flavin
spectrum and such variations can also be ascribed to interactions in the protein
microenvironment; in fact the flavin cofactor can interact with the protein in
many different ways. Usually it is tightly but noncovalently bound to the pro-
tein, however in some cases the cofactor is covalently linked to the polypeptide
chain perturbing spectral features of the flavoprotein. Trying to investigate if
some covalently bond could affect such spectrum perturbation, protein denat-
uration with TCA (trichloroacetic acid) was performed. Treatment using 5%
TCA results in apoprotein precipitation with the removal of the noncovalently
linked flavin remaining in the soluble fraction of the sample (Fig. 4.8).
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Figure 4.9: Uv-visible spectrum of the soluble fraction after protein denaturation
with TCA (trichloroacetic acid) and containing the noncovalently linked flavin cofactor.
In the case of covalently bound cofactor, the flavin cofactor would copre-
cipitate together with the protein during the denaturation step, resulting in a
yellow protein precipitate. This was clearly not the case for the studied BVMOs.
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Variations in the flavin or in its protein environments can be also due to the
binding of substrates, substrate analogues and inhibitors [67]. Titrations with
the compound of interest can yield valuable information concerning changes in
the active site environment.
As elucidated by Sheng et al. for CHMO from Acinetobacter sp. [100] and by
Torres Pazmin˜o for PAMO [79], spectral changes of the flavin are observed upon
binding of NADP+. Thus, titration of 12 µM Cm-BVMO with 0-100 µM NADP+
was investigated by monitoring changes in the UV-visible region of the flavin ab-
sorption spectrum (Fig. 4.9). To determine at which wavelengths big differences
were presented, difference spectra obtained by subtraction of the wild-type Cm-
BVMO spectrum and the recorded ones at different NADP+ concentrations were
calculated and plotted (Fig. 4.10). The largest decrease in absorbance was ob-
served at 395 nm. In fact, experimental data indicate that the addition of 5
µM NADP+ is sufficient for a more pronounced depression between to the two
typical peaks (Fig 4.9) resulting in a better-resolved flavin spectrum. Moreover,
we also noticed that the variation of the spectrum is achieved by just adding 5
µM NADP+ which is around the half of the enzyme concentration (12 µM). By
considering that spectra referred to other NADP+ concentrations do not show
relevant variations, it might be hypothesized that the oxidized Cm-BVMO could
still contain some bound NADP+.
Nevertheless, by analysing this preliminary study we can surely conclude
that the affinity of the enzyme for NADP+ is relatively high. This is in line with
determined low K M value for NADPH. More a detailed kinetic analysis it would
be interesting to better understand if there is any role of the oxidized coenzyme
concerning changes around the flavin or in the active site environment.
Concluding remarks
In the reported study, a biocatalytic characterization of the newly discovered
type I BVMOs Cm, Pp from photosynthetic eukaryotes and the corresponding
mutant PpY173H was carried out. Optimization of reaction conditions in terms
of optimal pH and temperature values were performed. Also the thermody-
namic stability measured as protein melting temperature (Tm) was investigated.
ThermoFAD assay was used to determine Tm values for all the three enzymes
revealing that Cm represent a thermostable type I BVMO. The substrate pro-
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Fig 4.12. Flavin absorbance spectra of 12 µM Cm-BVMO upon titration with NADP+. The concentration 
of NADP+ is varied from 0 to 100 µM. 
 
 
 
 
 
 
 
 
 
 
Fig. 4.13. Difference spectra of Cm-BVMO upon titration with NADP+ using the spectrum of Cm-
BVMO with no NADP+ as reference. 
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Figure 4.10: Flavin bsorb nce spectra of 12 µM Cm-BVMO upon titration with
NADP+. The concentration of NADP+ is varied from 0 to 100 µM.
Figure 4.11: Difference spectra of Cm-BVMO upon titration with NADP+ using the
spectrum of Cm-BVMO with no NADP+ as reference.
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files were found to be quite versatile. The BVMOs can be used to catalyse the
Baeyer-Villiger reaction of aliphatic, arylaliphatic and bicyclic ketones. In par-
ticular linear aliphatic ketones (C9 and C12), carring the keto functionality in
different positions, have been the best substrates in steady state kinetic analysis
and together with phenylacetone the best converted in enzymatic assay and bio-
conversions. Biooxidation of the well-known bicyclo[3.2.0]hept-2-en-6-one led to
the production of all four possible lactone products for the three BVMOs, and the
observed ee values suggest poor enantioselectivity towards this racemic substrate.
The “normal” lactone was the main product for both, fast and slow reactions.
The studies enzymes were found to be rather slow. Such moderate/low k cat and
k cat/K M values are typical of enzymes operating in secondary metabolism sub-
jected to a weak selective pressure. The enzymes may be involved in modifying
some special secondary metabolites. Alternatively, the current study did not
include compounds that resemble the physiological substrate for the discovered
BVMOs.
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5.1 Summing up
Biocatalysis utilizes enzymes or whole cells as natural catalysts in chemical trans-
formations. Since several decades it has played a central role in turning chemical
processes green, to realize a more sustainable chemistry. In fact, the aim of
”Green Chemistry” is the design of products and processes that minimize the
use and generation of hazardous substances. Compared to chemical processes,
biocatalysis offers important advantages such as mild reaction conditions, which
minimizes problems of undesired side-reactions, and complete degradation in the
environment. The most significant advantage is the high selectivity of enzymes,
a keyword in organic synthesis because of the necessity to obtain enantiopure
compounds. For these reasons chemical industry has progressively revealed its
interest in biocatalysis, which is becoming a useful tool to design new processes
for the production of fine chemicals, more compatible and respectful for the
natural environment.
Monooxygenases are a class of oxidizing enzymes considerably appealing for
industrial uses because of the reaction they are able to catalyze. It consists
in the transfer of one oxygen atom from molecular oxygen to an organic sub-
strate, reducing the other oxygen atom to water. In particular, Baeyer-Villiger
monooxygenases (BVMOs) can perform oxidation of a ketone to an ester (Baeyer-
Villiger oxidation) but also sulfoxidations and other oxidation reactions, often
with good chemo-, regio- and enantio-selectivity. The latter feature is impos-
sible to be obtained by the equivalent chemical methods. From an industrial
point of view, the great potential of these enzymes is the possibility to produce
chiral lactones and sulfoxides by asymmetric synthesis, resulting attractive for
organic synthesis. Baeyer-Villiger monooxygenases (BVMOs) contain a flavin
cofactor, FAD or FMN, which is tightly bound to the enzyme. The main de-
scribed and characterized enzymes are type I BVMOs, containing FAD and using
NADPH as electron donor. They consist in a single polypeptide chain having
two Rossman-fold motifs responsible for the binding of FAD and NADPH. In
addition, type I BVMOs contain a precise motif (FxGxxxHxxxWP/D) that is
a conserved BVMO-specific sequence used for the identification of novel type I
BVMO genes by the genome-mining approach.
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Because of the development of bioinformatics tools and the increase of se-
quenced genomes in public database, it is possible to discover new enzymes by
simply performing an in silico search using the program BLAST, which finds
conserved regions among sequences. Till last year, all identified putative BVMO
genes originated from bacteria or fungi. The first eukaryotic BVMO cloned and
expressed has been cycloalkalone monooxygenases from the ascomycete Clyn-
drocarpon radicicola ATCC 11011, in 2012 [63]. Up to now, no BVMO has
been found in archea or higher eukaryotes. By genome mining using PAMO,
which is the best-known and characterized type I BVMOs, as bait sequence and
the “fingerprint” motif FxGxxxHxxxWP/D as discriminant, we have identified
and selected five new putative BVMOs from different organisms: Oryza sativa
(plant), Physcomitrella patens (moss), Cyanidioschyzon merolae (red alga), Tri-
chodesmium erythraeum (cyanobacterium), Haloterrigena turkmenica (archeabac-
terium). In particular, basing on most updated literature, the photosynthetic
eukaryotes Oryza, Physcomitrella and Cyanidioschyzon would result very un-
common sources for BVMOs.
To obtain the identified putative type I BVMOs in recombinant form, a
cloning strategy was set up and was the same for all the five sequences. The
expression vectors were created starting from the same pET-28a(+) plasmid, in
which the different Ht-BVMO, Te-BVMO, Os-BVMO, Cm-BVMO, Pp-BVMO
coding sequences were inserted. Such sequences were obtained by two subse-
quent PCR reactions, the first one producing a preliminary amplimer, used for
the second mutagenic amplification introducing proper restriction sites. The
only difference between the five sequences was the starting material, genomic
DNA for Te-BVMO, Cm-BVMO, Pp-BVMO, and purchased plasmid DNA for
Ht-BVMO and Os-BVMO. The obtained constructs were transformed in E. coli
BL21 (DE3) and overexpression tests were performed: in order to obtain sol-
uble proteins, parameters such as expression temperature, IPTG concentration
and suitable strains were varied. Paradoxically, the very high level of expression
obtained for all apart one BVMOs resulted in a disadvantage. In fact, it exacer-
bated the insolubility of the recombinant proteins, which was the main bottleneck
encountered in the whole work. Different arrangements were tried to slow down
translation, the classical strategy adopted to favor protein folding, but no one
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was fully effective. On the contrary, addition in the culture medium of an excess
of riboflavin, the precursor of the FAD, was successful in order to obtain soluble
recombinant proteins, at least for Pp-BVMO (Physcomitrella patens) and Cm-
BVMO (Cyanidioschyzon merolae). Both of them were successfully purified by
IMAC chromatography. Moreover, a mutant form of Pp-BVMO with a restored
histidine (H) in the “fingerprint” motif FxGxxxHxxxWP/D (a tyrosine in the
wild-type sequence) was obtained by site directed mutagenesis.
A biocatalytic characterization of the new photosynthetic eukaryotic type I
BVMOs, Cm-BVMO, Pp-BVMO and the mutant PpY173H-BVMO, was carried
out. The optimal pH found is 8.5 for Cm- and 8.0 for Pp- and PpY173H- BV-
MOs. While the latter two enzymes have a temperature optimum around 25◦C,
Cm-BVMO shows high resistance to temperature. The TermoFAD assay used
to determine Tm values revealed that the recombinant Cm-enzyme represents
a considerable thermostable type I BVMO. To evaluate the synthetic potential
of these new type I BVMOs a broad range of substrates was used in a prelimi-
nary phosphate assay. Substrate profiles seems to be versatile; the enzymes can
oxidize linear and cyclic aliphatic ketones, aryl and aromatic ketones. Linear
ketones (C8 and C12) have proven to be the best substrates and steady-state
analysis and conversions confirmed this result. Racemic bicyclo[3.2.0]hept-2-en-
6-one, typically used to probe the biocatalytic potential of BVMOs, was oxidized
by Cm-, Pp- and PpY173H- BVMOs giving the four possible lactone products
with poor enantioselectivity. By steady-state analysis, it was observed that ki-
netic parameters such as K M, k cat and k cat/K M displayed considerable low values
suggesting a potential role as secondary metabolism enzymes. Probably the se-
lective pressure applied on them is not enough strong, resulting in moderate/low
k cat and k cat/K M values. Also for this reason their natural substrates remain yet
to be identified.
Overall, Baeyer-Villiger monooxygenases (BVMOs) are useful oxidizing en-
zymes important for organic synthesis. We have discovered new type I BVMOs
from very unusual sources, contributing to increase the number of available re-
combinant type I BVMOs and to enlarge the toolbox for their synthetic utility.
112
Chapter 5. Summary and Conclusions
5.2 Outlooks
The presented work has brought to the discovery of new type I BVMOs able to
perform oxidation reactions of chemical interest. Being the first discovered type I
BVMOs from photosynthetic eukaryotes, natural substrates and reactions are yet
unknown. Nevertheless, the performed biocatalytic characterization has given us
some indications about their substrate profile and efficiency as biocatalysts. To
gain more information about their structure-to-function relationships, 3D protein
structures would be very helpful. Obtaining crystals from the obtained recombi-
nant proteins would be a fundamental goal, since the structure of proteins gives
much more insight in their function: it reveals how they are built and how they
work, and allows prediction for their reactivity and for other properties. Knowl-
edge of positions and interactions between amino acids residues, for example in
the active site of an enzyme, would be a good starting point for protein engineer-
ing, in order to improve substrate acceptance, selectivity and catalytic efficiency.
Indeed, native enzymes hardly fit the demanding requests imposed by synthetic
applications; enzyme engineering is usually the solution adopted to make them
suitable for required properties. Many approaches have been developed to allow
the production of engineered enzymes having useful qualities such as increased
activity, modified specificity or selectivity [14]. Rational design was one of the
first approaches put forward to obtain desired changes: it consists in site-directed
mutagenesis of chosen amino acids and obviously requires a detailed knowledge
of the structure and function of the target protein. During the last two decades
directed evolution has became a more attractive strategy for the modification
of enzyme properties. It initially consists in generating molecular diversity by
subsequent rounds of random mutagenesis and in identifying improved enzyme
variants by high-throughput screening or selection after each round. The advan-
tage of directed evolution is that it does not require knowledge of the protein.
However, actual exploitation of directed evolution is strictly dependent on con-
siderable instrumental and energy resources, to achieve the most stable, selective
and productive biocatalyst. Recently, a semi-rational method to evolve enzymes
has been developed consisting in a rational approach combined with stochastic
elements [23, 66]. By utilizing information on protein sequence and structure,
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it is possible to preselect promising target sites and to exhaustively modify only
identified residues. There are many examples of protein-engineering for BV-
MOs demonstrating that activity, substrate range, stability and selectivity can
be successfully improved [53].
Moreover, exploitation of the genetic properties of Phiscomitrella patens could
be helpful for better understanding the functional role of the native Pp-BVMO.
As previously reported, Phiscomitrella patens is a model organism used for stud-
ies in plant evolution, development and physiology. It displays a highly efficient
homologous recombination, meaning that an exogenous DNA sequence can be
targeted to a specific genomic position (by gene targeting) to create knockout
mosses. This approach represents a powerful method to study the function of a
gene [95, 94].
Finally, obtaining the crystallographic structure of the new Cm-, Pp- and
PpY173H- type I BVMOs could enable a better understanding of structural,
functional and phylogenetic relationships. More information concerning all these
aspects could help to elucidate their natural role and facilitate their enhance-
ments by protein engineering. In general, we think that all mentioned efforts
could help in characterizing the new Baeyer-Villiger monooxygenases and in plan-
ning their transformation into more versatile enzymes, able to meet the strict
demands of specific applications in organic synthesis.
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6.1 Materials
6.1.1 Primers
P. patens
sequence 5’ - 3’
Pp3 for ACAGGCCACGGGGGTAGTTCTGTTG
Pp4 rev CAACCCTGGACAGCATCGGAAGCCT
Pp1 for AAGTATGTCCAATTCCATGGCTGAGTTCGATGCTGTTATAGTCGGAG
Pp2 rev AAACAATGCCCGCGGCCGCCAGCTTGAATCCC
Pp5 seq for AAGGCTCATCGTACTACACGGG
Oryza sativa
sequence 5’ - 3’
sp6 for GATTTAGGTGACACTATAG
T7 term GCTAGTTATTGCTCAGCGG
Os 1 for CACACCCACCATGGCCCAGCATTACGACG
Os 2 rev CTTGTTCAGGCGGCCGCGAGGTCGTATCC
Os3 seq for TTTGTTCGCACGCCCAACCT
C. merolae
sequence 5’ - 3’
Cm3 for AGTGATGCGCGTGGCCGGCA
Cm4 rev AGGTGTCTGCACCTCGCCAGCG
Cm1 for TTTGACCGGCCATGGGAGCGGAGCTCAAC
Cm2 rev GCATCCACCGCGCCGGCGTACAGCGAAG
Cm 5 seq for ATCTTCCACACCGCTCGTTGG
T. erythraeum.
sequence 5’ - 3’
Te5 for AGCCTAGTTCCTGATTGGGTTGGTT
Te6 rev GGCCTGAGGAGAACACATACAAGCT
Te1 for TTGTTAGAGCAATTACCATGGATAATCAAATTTCTAGTAACCC
Te2 rev AAAGTCTTTGGCGGCCGCTTGAGAAGTTGTGAG
Te8 for CGTAGCGCGCCGTGGATCGCACC
Te9 rev GGTGCGATCCACGGCGCGCTACG
Te7 seq for TGGCGTATTTATAGTGCCTCTGGG
H. turkmenica
sequence 5’ - 3’
Ht1 seq for CGTGTTGGTCTGGTTGGTAC
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6.1.2 Nutrition media
Nutrition media were autoclaved for 20 min at 121◦C and agar (1.6% w/v) was
added in order to prepare solid media. Antibiotics and others non autoclavable
additives were filtrated (0.2 µm, Minisart, Sartorius).
E. coli
LB-medium (pH 7.0)
10 g tryptone
5 g yeast extract
10 g NaCl
TB-medium (pH 7.0) Buffer for TB-Medium
12 g peptone 125.4 g K2HPO4 (0.72 M)
24 g yeast extract 23.1 g KH2PO4 (0.17 M)
5 g glycerol
filled up to 900 ml with water
Cyanidioschizon merolae
M-Allen
(NH4)2SO4 262 mg
KH2PO4 54 mg
MgSO4 · 7H2O 50 mg
CaCl2 · 2H2O 14 mg
A2 trace element stock solution 0.2 mL
Distilled water 99.4 mL
pH 2.5 1)
After autoclaving, add 0.4 mL of A2 Fe stock solution (filter-sterilized).
1) Adjust to pH 2.5 using 0.5mol/L H2SO4.
A2 trace element stock solution
H3BO3 285 mg
MnCl2 · 4H2O 180 mg
ZnCl2 10.5 mg
Na2MoO4 · 2H2O 39 mg
CoCl2 · 6H2O 4 mg
CuCl2 · 2H2O 4.3 mg
Distilled water 100 mL
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A2 Fe stock solution
EDTA · 2Na 700 mg
FeCl3 · 6H2O 400 mg
Distilled water 100 mL
Phiscomitrella patens
Nutrition media were autoclaved for 20 min at 121◦C and plant agar (7 g/l)
was added in order to prepare solid media. Buffer Phosphate (1000X): 25 g di
PpNH4 rich medium (1liter in milliQ water):
CaNO3 . 4H2O 0.8g/l
MgSO4 . 7H2O 0.25g/l
FeSO4 . 7H2O 0.0125g/l
Phosphate buffer (1000X) 1 ml
Microelements stoks (1000X) 1 ml
NH4 tartrate 500mg/l
Glucose 5g/l
Microelements stock (1000X):
CuSO4 . 5H2O 55 mg/l
ZnSO4 . 7H2O 55 mg/l
H3BO3 614 mg/l
MnCl2 . 4H2O 389 mg/l
CoCl2 . 6H2O 55 mg/l
KI 28 mg/l
Na2MoO4 . 2H2O 25 mg/l
KH2PO4 are dissolved in 100 ml of milliQ water; the solution is adjusted to pH
7 using 4M KOH.
6.2 Methods
6.2.1 Reagents and Enzymes
All chemicals were purchased from Fluka and Sigma-Aldrich (Milan, Italy). Re-
striction enzymes were obtained from New England Biolabs (NEB) or Promega.
Phusion(TM) High-fidelity DNApolymerase was from Finnzymes. TSAP Ther-
mosensitive Alkaline Phosphatase was purchased from Promega, whereas T4
DNA Ligase from NEB. IMAC-Select Affinity Gel resin was from Sigma-Aldrich.
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6.2.2 PCR protocols
Oryza sativa
First PCR reaction (PCR1 Os)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Sp6 10 µM 2,5 µl Annealing 50 30sec
T7 term 10 µM 2,5 µl Extension 72 1min
pCMVFL3 0,3 µl (60 ng) Final extension 72 10min
H2O 33,2 µl
Total volume 50 µl
Mutagenic PCR reaction (PCR2 Os)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Os1for 10 µM 2,5 µl Annealing 57 30sec
Os2 rev 10 µM 2,5 µl Extension 72 1min
PCR1 Os 0,5µl Final extension 72 10min
H2O 33 µl
Total volume 50 µl
Phiscomitrella patens
First PCR reaction (PCR1 Pp)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Pp3 for 10 µM 2,5 µl Annealing 66 30sec
Pp4 rev 10 µM 2,5 µl Extension 72 1min
Genomic DNA 0,5 µl (22 ng) Final extension 72 10min
H2O 33µl
Total volume 50 µl
Mutagenic PCR reaction (PCR2 Pp)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Pp1for 10 µM 2,5 µl Annealing 66 30sec
Pp2 rev 10 µM 2,5 µl Extension 72 1min
PCR1 Pp 0,5 µl Final extension 72 10min
H2O 33 µl
Total volume 50 µl
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Cyanidioschizon merolae
First PCR reaction (PCR1 Cm)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Cm3 for 10 µM 2,5 µl Annealing 64 30sec
Cm4 rev 10 µM 2,5 µl Extension 72 1min
Genomic DNA 0,5 µl (100 ng) Final extension 72 10min
H2O 33 µl
Total volume 50 µl
Mutagenic PCR reaction (PCR2 Cm)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Cm1for 10 µM 2,5 µl Annealing 72 30sec
Cm2 rev 10 µM 2,5 µl Extension 72 90sec
PCR1 Cm 0,5 µl Final extension 72 10min
H2O 33 µl
Total volume 50 µl
Trichodesmium erythraeum
First PCR reaction (PCR1 Te)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Te5 for 10 µM 2,5 µl Annealing 57 30sec
Te6 rev 10 µM 2,5 µl Extension 72 1min
Genomic DNA 0,5 µl (27 ng) Final extension 72 10min
H2O 33 µl
Total volume 50 µl
PCR reaction (Te1-Te9)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Te1 for 10 µM 2,5 µl Annealing 61 30sec
Te9 rev 10 µM 2,5 µl Extension 72 90sec
PCR1 Te 0,5 µl Final extension 72 10min
H2O 33 µl
Total volume 50 µl
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PCR reaction (Te8-Te2)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Te8 for 10 µM 2,5 µl Annealing 61 30sec
Te2 rev 10 µM 2,5 µl Extension 72 90sec
PCR1 Te 0,5 µl Final extension 72 10min
H2O 33 µl
Total volume 50 µl
PCR reaction (Te1-Te9)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Te1for 10 µM 2,5 µl Annealing 61 30sec
Te9 rev 10 µM 2,5 µl Extension 72 90sec
PCR1 Te 0,5 µl Final extension 72 10min
H2O 33 µl
Total volume 50 µl
PCR reaction (Final)
Phusion HC Buffer 5X 10 µl Temp (◦C) time
dNTPs 10mM 1 µl Initial denaturation 98 30sec
Phusion DNA polymerase 0,5 µl Denaturation 98 10sec
Te1for 10 µM 2,5 µl Annealing 61 30sec
Te2 rev 10 µM 2,5 µl Extension 72 90sec
PCR Te1-Te9 + PCR Te8-Te2 0,5 µl Final extension 72 10min
H2O 33 µl
Total volume 50 µl
Colony PCR
GoTaq 5x Reaction Buffer 10 µl Temp (◦C) time
dNTPs 10mM 1µl Initial denaturation 94 5min
Primer “seq” 10 µM 2,5 µl Denaturation 94 1min
Primer T7 term 10 µM 2,5 µl Annealing 54 45sec
GoTaq Promega (5u/µl) 0,4 µl Extension 72 90sec
H2O 33,6 µl Final Extension 72 10min
Total volume 50 µl
6.2.3 Expression
The pET28a constructs containing the relative BVMO gene were transformed
into E. coli BL21 (DE3) or E.coli ArcticExpress. Preculture were carried out in
5 ml LB medium at 37◦C containing 50 µg/ml of kanamycin. Big culture were
carried out using E. coli BL21(DE3) in 1L LB medium with riboflavin addition
(100 µM). The cells were grown in shacking incubator at 37◦C to an optical
density at 600 nm (OD600) of 0.4-0.6, then induce by the addition of IPTG to a
final concentration of 0.2 mM and cultivated at 18◦C over night. The, cells were
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harvested by centrifugation (4◦C, 10 min, 4500xg) and washed with Tris/HCl
buffer (Tris 50 mM, pH 8.0). Cell disruption was carried out using French Press
and crude extract was centrifugated (4◦C, 20 min, 15000xg) to separate soluble e
insoluble fractions. FAD cofactor (100 µM) was added at the crude extract before
cell disruption. To verify the expression of the BVMO, samples were normalized
by OD600, denatured with a SDS buffer, centrifugated, resuspended and used for
SDS-PAGE analysis. To verify the identity of the protein also immunoblotting
assay was performed using anti His-tag antibody.
6.2.4 Enzyme purification and concentration
Overexpressed BVMOs were purified using His6-Tag metal ion affinity chro-
matography. The soluble fractions obtained from 1l culture were incubated to-
gether with the column material for 1h at 4◦C and then load on a 5 ml column
(Biorad). The column was washed by gravitational flow, first with three column
volumes of the 50 mM Tris/HCl and 300 mM of NaCl and, then twice with the
same buffer with the addition of 5 mM of imidazole. The elution of the His-
tagged BVMOs were performed with five column volumes of 50 mM Tris/HCl
containing 300 mM of imidazole. Excess of imidazole was removed using an
Econo-PAC 10DG desalting column (BioRad). The enzyme concentration was
measured by calculation the concentration of free flavin in a solution of dena-
tured protein. In fact the concentration of the flavoenzyme is in this case equal
to the concentration of free flavin. Using the law of Lambert-Beer A=l·ε·[flavin]
is possible calculate this concentration.
6.2.5 Activity assay, kinetics and TermoFAD
BVMO activity is usually determined spectrophotometrically by monitoring the
decrease of NADPH at 340 nm (ε= 6.22 mM-1 cm-1). Reaction mixtures (1
ml) contained 50 mM Tris–HCl buffer pH 8.0, 100 µM NADPH, 0,4 µM of pure
enzyme, and 10 µl of 1 mM of bicyclo[3.2.0]hept-2-en-6-one in dioxane. The
reaction was started by adding the enzyme to the mixture. One unit of BVMO
is defined as the amount of protein that oxidizes 1 µmol NADPH per minute.
Steady-state kinetic parameters of the different substrates were determined
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using purified enzymes and using substrate concentrations ranging from 0 to 5
mM. Data were fitted using the Michaelis-Menten equation using the program
SigmaPlot.
The unfolding temperatures, (Tm), were determined using the ThermoFAD
method. 30 µl of 1 mg/mL protein in Tris-HCl buffer (50 mM, pH 7.5) were
loaded in a Real Time PCR machine (Eppendorf) fitted with a 470 – 543 nm
excitation filter and a SYBR Green emission filter (523 – 543 nm). A temperature
gradient from 20 to 90 ◦C was applied (1◦C/min), and fluorescence data was
recorded. A sigmoidal curve was obtained after plotting the fluorescence against
the temperature. The unfolding temperature, Tm, is then determined as the
maximum of the derivative of this sigmoidal curve [34].
6.2.6 Substrate screening
For the phosphate activity assay, 100 µl 50 mM Tris–HCl (pH 7.5), containing 1
or 5 mM substrate, 100 µM NADPH, 10 µM PTDH, 10 mM sodium phosphite
and 1 µM BVMO was incubated at 25◦C for 2 h. Twenty µl of the reaction
mixture was than mixed with 200 µl molybdate reagent (10 mM (NH4)6Mo7O24
4H2O, 100 mM Zn acetate, pH 5, adjusted with HCl) and 50 µl 10% ascorbic
acid (pH 5, adjusted with 40% NaOH). During incubation of 30 min at 30◦C
a blue colored complex formed due to the phosphate generated during the ox-
idation reaction. By measuring the absorption at 600 nm, the concentration
of produced phosphate is quantitatively determined using a calibration curve.
Each conversion can be performed with a standard amount of BVMO allowing
a comparison between samples. All substrates tested in 96 wells plates and were
dissolved in dioxane (maximum 5%).
6.2.7 Conversions and GC/GC-MS analysis
For GC and GC-MS analysis, 500 µl incubations of 50 mM Tris–HCl (pH 7.5),
containing 2 mM substrate, 5% dioxane, 100 µM NADPH, 3.0 µM PTDH, 10
mM phosphite and 1 µM BVMOs was incubated shaking at 25◦C from 1h to 20
h. The reactions were then stopped by extracting with ethyl acetate (3 x 0.5 ml,
including 0.1% mesitylene as an internal standard), dried with magnesium sulfate
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and analyzed directly by GC or GC-MS to determine the degree of conversion.
Columns used:
- GC-Helifex AT5
- Chirasil Dex CB
- GC-MS HP1
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Columns used: 
- GC-Helifex AT5 
- Chirasil Dex CB 
- GC-MS HP1 
Compound Column  program tR (min) substrate tR (min) product 
Phenylacetone AT5 (GC) 
2min at 100°C 
100°C!120°C 5°C/min 
120°C!160°C 20°C/min  
6.9 7.5 
Cyclopentanone AT5 (GC) 
5min at 50°C 
50°C!120°C 5°C/min 
120°C!150°C 15°C/min  
5.5 14.7 
Cyclohexanone AT5 (GC) 
5min at 50°C 
50°C!120°C 5°C/min 
120°C!150°C 15°C/min 
9.0 17.7 
Bicyclohept-2-en-
6-one 
Chiraldex CB 
(GC) 
35°C!130°C 10°C/min 
12min at 130°C 
130°C!35°C 10°C/min 
9.0 
9.2 
16.5 A (1R,5S) 
16.9 N (1R,5S) 
17.2 A (1S,5R) 
17.4 N (1S,5R) 
Octanal  HP1 (GC-MS) 70°C!120°C 5°C/min 120°C!280°C 20°C/min 7.4 8.5 
2-octanone HP1 (GC-MS) 70°C!120°C 5°C/min 120°C!280°C 20°C/min 8.1 8.9 
3-octanone HP1 (GC-MS) 70°C!120°C 5°C/min 120°C!280°C 20°C/min 7.9 8.7 
4-octanone HP1 (GC-MS) 70°C!120°C 5°C/min 120°C!280°C 20°C/min 7.5 8.3 
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Substrate structures:
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